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P1
Medical simulation for severe sepsis: improving both factual
knowledge and crisis management skills
Peter G Brindley
Critical Care Medicine, University of Alberta, Edmonton, Canada
Critical Care 2008, 12(Suppl 5):P1 (doi: 10.1186/cc7034)
Background  The morbidity and mortality from severe sepsis
depends largely on how quickly and comprehensively evidence-
based therapies are administered. As such, a huge opportunity
exists. However, optimal care requires not only factual knowledge,
but also numerous practical strategies including the ability to
recognize a disease, to identify impending crises, to communicate
effectively, to run a team, to work under stress and to simul-
taneously coordinate multiple tasks. Medical simulation offers a
way to practice these essential crisis management skills, and with-
out any risk to patients.
Methods Following a didactic lecture on the key components of
the Surviving Sepsis Campaign Guidelines, we trained 20 emer-
gency medicine residents on a portable Laerdal Patient Simulator.
Pre-programmed sepsis scenarios were developed following a
needs assessment and modified Delphi technique. To maximize
realism, this was performed in the acute care area of the
Emergency Department and included a pre-briefed respiratory
therapist and nurse. We videotaped resident performance and
provided nonpunitive feedback, focusing on the comprehensive-
ness of therapy (for example, whether broad-spectrum antibiotics
were given) and crisis resource management strategies (for
example, whether help was asked for and tasks were appropriately
allocated).
Results  Evaluation using a five-point Likert scale demonstrated
that participants found this very useful (4.5/5), that lessons were
complementary and supplementary to those learned from lectures
(4.5/5) and that medical simulation was realistic (4/5). In addition,
despite prior sepsis lectures, comparison of pre-tests and post-
tests showed that more emergency medicine residents would:
administer broad-spectrum antibiotics as soon as possible
following hypotension (14/20 pre-test, compared with 16/20 post-
test), administer low-dose corticosteroids for those with refractory
shock (10/20 pre-test, compared with 13/20 post-test), and would
favour norepinephrine as a vasopressor (8/20 pre-test, compared
with 12/20 post-test). Participants specifically valued the chance
to observe and practice crisis resource management skills, which
they felt had not been previously addressed (19/20).
Conclusion Medical simulation appears to be an effective way to
change both knowledge and behaviours in the treatment of severe
sepsis. Many education and licensing boards also expect trainees
to become not only content experts, but also effective communi-
cators, collaborators, resource managers and advocates. These
laudable goals are difficult to capture with traditional lectures but
are comparably easy using medical simulation. We hope others will
consider medical simulation as a complementary teaching and
quality-assurance strategy in the fight against sepsis.
P2
Protective potential of 2-chloroadenosine in Klebsiella
pneumoniae B5055 induced sepsis in BALB/c mice
Vijay Kumar, Sanjay Chhibber
Department of Microbiology, Panjab University, Chandigarh, India
Critical Care 2008, 12(Suppl 5):P2 (doi: 10.1186/cc7035)
Background  The incidence of sepsis or systemic inflammatory
response syndrome in both developing countries as well as in the
developed countries is rising despite the extensive research in
understanding the molecular basis of sepsis pathogenesis. Sepsis
is currently treated with antibiotics along with various adjunctive
therapies. However, current existing therapies do not provide much
efficacy in terms of patient survival and development of multiorgan
dysfunction during sepsis.
Methods  In the present study, we have developed the murine
model of sepsis by placing Klebsiella pneumoniae B5055
entrapped in fibrin-thrombin clot in the peritoneal cavity of BALB/c
mice. The mice were subsequently treated with adenosine analog
2-chloroadenosine (10 μg/kg/day intravenously). The efficacy of 2-
chloroadenosine was investigated in terms of survival of animals
and various inflammatory parameters (that is, malondiadehyde,
myeloperoxidase, nitric oxide) in the lungs, liver and serum. Also
the levels of proinflammatory cytokines (that is, TNFα and IL-1α)
were determined.
Results  The 2-chloroadenosine treatment significantly improved
the survival of animals over a period of 5 days and increased the
survival of animals to 70% as compared with the control group
where 100% mortality was observed. The 2-chloroadenosine treat-
ment significantly (P<0.05) decreased the production of TNFα, IL-1α
and malondiadehyde, myeloperoxidase, and nitric oxide production
in the serum, lung and liver of mice.
Conclusion  The 2-chloroadenosine protected the mice from
sepsis by increasing their survival and by decreasing the produc-
tion of inflammatory markers investigated in the study.
P3
Use of clinical decision support to improve compliance with
the Surviving Sepsis Campaign
Erica Cummings1, Gerhard Tivig1, LuAnn Staul2, 
Michele Lecardo3
1Philips Healthcare, Andover, Massachusetts, USA; 2Lagacy
Healthcare, Portland, Oregon, USA; 3St Vincent’s Hospital,
Bridgeport, Connecticut, USA
Critical Care 2008, 12(Suppl 5):P3 (doi: 10.1186/cc7036)
Background Evidence suggests that early, timely and aggressive
resuscitation for patients with septic shock can have a significant
impact on both morbidity and mortality. However, even with the
widespread awareness of the Surviving Sepsis Campaign (SSC)
guidelines, adherence varies widely. It has been shown that clinical
decision support systems can help clinicians improve variousS2
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aspects of clinical practice, particularly when they are integrated
into clinical practice and present at the point of care. Protocol
Watch (PW) was developed as a bedside tool to assist clinicians
with both implementation of and compliance with the SSC
guidelines. The purpose of this research was to measure the
impact that using PW had on adherence to the SSC guidelines.
Methods  Participants were critically ill patients in two large
university-affiliated teaching hospital intensive care units in the
United States. Prior to the installation of PW, implementation of the
SSC guidelines was done using a paper-based system of standing
orders. Baseline data on compliance with the SSC guidelines were
collected. PW, which offers an electronic version of the guidelines
and is resident on the bedside patient monitor, was then installed
in all critical care beds. The post PW installation data collection is
currently being collected.
Results Preliminary results show improvements in compliance with
the resuscitation bundle, improved compliance with antibiotic
administration, and a decreased time for completion of the resusci-
tation and management bundles and antibiotic administration (see
Table 1). In addition, the feedback from the clinical users has been
extremely positive.
Conclusion  If the final data analysis supports the preliminary
findings, PW could emerge as an important method for assisting in
the implementation of the SSC guidelines, thus making a valuable
contribution in the care of critically ill patients with sepsis.
P4
Prognostic value of amino terminal pro-b-type natriuretic
peptide in septic patients
Fernando Maroto, Cristobal Colon, Olga Rufo, Ana Barrero,
Victor Jorge, Sonia Gallego, Flora Villarrasa, Maria Carmen
Perez-Paredes, Jose Luis Garcia-Garmendia
Intensive Care Unit, Hospital San Juan de Dios, Bormujos, Sevilla,
Spain
Critical Care 2008, 12(Suppl 5):P4 (doi: 10.1186/cc7037)
Background  Amino terminal pro-B-type natriuretic peptide (NT
proBNP) has been demonstrated high in septic patients. Our
objective was to analyze the behavior of this biomarker and its
prognostic value in a cohort of septic patients admitted to the ICU.
Methods  A prospective cohort study was carried out in septic
patients admitted to the ICU. The analyzed variables were demo-
graphic characteristics, severity scales, empiric antibiotic treat-
ment, determination of NT proBNP and mortality. A univariate
analysis and a multivariate logistic regression on mortality using
SPSS 12.0 were conducted.
Results  We included 98 patients, 37% female, age 64 years
(standard deviation, 16). The median Acute Physiology and Chronic
Health Evaluation II score was 18 (standard deviation, 7) and the
median Sepsis-related Organ Failure Assessment score was 7
(standard deviation, 5). Occurrence of medical sepsis was 55%. The
most common focus was abdominal (40%), followed by pneumonia
(32%) and urine (16%). The ICU mortality was 22.7% and the
hospital mortality was 30%. The values of NT proPNB were higher in
patients with septic shock (P= 0.001) and with acute kidney failure
(creatinine >2 mg/l) (P<0.001). There was a linear correlation
between the values of NT proPNB and creatinine (r2= 0.33,
P<0.001). The values of NT proPNB at admission were significantly
higher in patients who died in the ICU (P= 0.027). In the multivariate
analysis, the variables significantly associated with mortality were
Acute Physiology and Chronic Health Evaluation II score, the female
sex, inadequate empiric antibiotic treatment, fungal infection or Gram-
positive infection and the presence of mechanical ventilation. In the
analysis of those 66 cases with NT proPNB values seriated, the
variables independently associated with mortality in the ICU were
inadequate empirical antimicrobial treatment, Sepsis-related Organ
Failure Assessment score at 24 hours, acute kidney failure and
deterioration in the values of NT proPNB.
Conclusion  The admission values for NT proPNB of septic
patients in the ICU do not add significant information for prognosis,
but are indicators of cardiovascular and renal dysfunction. The
worsening of these values during admission appears to be
associated with increased mortality in the ICU.
P5
Compliance with vasopressor use of early goal-directed
therapy is not associated with decreased mortality in severe
sepsis/septic shock
Bekele Afessa, John J Mullon, Rodrigo Cartin-Ceba, 
Garrett E Schramm, Ognjen Gajic
Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester,
Minnesota, USA
Critical Care 2008, 12(Suppl 5):P5 (doi: 10.1186/cc7038)
Background Early goal-directed therapy (EGDT) reduces mortality
of severe sepsis/septic shock by 16%. The elements of EGDT
include central venous pressure (CVP) and central venous oxygen
saturation (ScvO2) monitoring, administration of intravenous fluid to
achieve CVP of 8 to 12 mmHg, administration of vasopressors,
transfusion of red cells (RBC), and administration of inotropes. This
prospective observational study aims to determine the impact of
complying with each of these six EGDT elements.
Methods  The study included patients with severe sepsis/septic
shock treated in our ICU. We collected demographics and the
Acute Physiology and Chronic Health Evaluation III probability of
death, compliance with each of the six EGDT elements within
6 hours of severe sepsis/septic shock onset and hospital mortality.
The probability of hospital death at ICU admission, sepsis stage
(severe or shock), and compliance with each EGDT element were
entered into a multivariate logistic regression model. P <0.05 was
considered statistically significant.
Results Excluding 31 patients who did not authorize the research,
530 patients, 355 (67%) with septic shock, were included in the
study. The compliance rates with the six elements were: inotrope
Table 1 (abstract P3)
Mean values for age, Acute Physiology and Chronic Health Evaluation (APACHE) II score, resuscitation/management bundle completion
and antibiotic administration for initial subjects
Time to antibiotic 
Age  APACHE II  Resuscitation bundle  Management bundle  administration 
(years) score completion (time) completion (time) (minutes)
Group 1 (n = 39), prior to PW 67.6 21.2  61.5% (11.6 hours) 85.2% (21.1 hours) 201
Group 2 (n = 46), after PW implementation 61.7 21.6  72.1% (9.1 hours) 85.3 (16.3 hours) 144S3
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use 50%, ScvO2 measurement 60%, adequate fluid resuscitation
69%, RBC transfusion 83%, CVP monitoring 83%, and vaso-
pressor use 89%. The observed and predicted hospital rates were
33% and 36%, respectively. Shock (odds ratio (OR), 95% confi-
dence interval (CI) = 2.13, 1.27 to 3.58; P = 0.004) and predicted
mortality (%) (OR, 95% CI = 1.04, 1.03 to 1.05; P <0.001) and
compliance with use of vasoactive drugs (OR, 95% CI = 2.93,
1.25 to 6.86; P = 0.013) were independently associated with
mortality. There was no independent association between hospital
mortality and inotrope use, ScvO2, adequate fluid resuscitation,
RBC transfusion, and CVP monitoring.
Conclusion Compliance with vasopressor use of EGDT may not
improve survival in severe sepsis/septic shock. Further studies are
needed to determine which elements of EGDT improve outcome.
P6
Pseudomonas aeruginosa elastase induces IL-8 production in
the lung cells via the epidermal growth factor/extracellular
signal-regulated proteins/NFκ κB pathway
Ali Azghani
Department of Biology, The University of Texas at Tyler, Tyler,
Texas, USA
Critical Care 2008, 12(Suppl 5):P6 (doi: 10.1186/cc7039)
Background The induction of chemokine secretion by fibroblasts
is crucial for the migration of leukocytes into the parenchyma of the
injured lung. Several bacterial products activate the lung’s struc-
tural as well as immune cells to produce proinflammatory cytokines
and chemokines. We report that elastase from Pseudomonas
aeruginosa (PE) evokes IL-8 mRNA expression and protein
secretion in nonmalignant culture of human lung fibroblasts by
activating the receptor for epidermal growth factor (EGFR) and
downstream mitogen-activated protein kinases (MAPK) pathway.
Methods We utilized western blot analysis to detect phosphory-
lation of EGFR and signal transduction intermediates. Northern
blot and ELISA analyses were used to determine IL-8 RNA
expression and cytokine secretion.
Results We found that the enzymatically active PE enhances IL-8
mRNA and protein secretion but does not increase IL-10 or TNF
expression. PE induces phosphorylation of the EGFR and the
extracellular signal-regulated proteins (ERK1/2) of the MAPK
pathway. Pretreatment of the cells with neutralizing antibody to
EGFR or the EGFR-specific tyrphostin AG1478 markedly attenuated
the PE-induced ERK1/2 activation. PE-induced IL-8 expression is
also abolished in the presence of the MEK inhibitor U0126,
indicating the involvement of ERK1/2 in this process.
Conclusion Taken together, the results show PE could modulate
lung inflammation by exploiting the EGFR/ERK/NFκB pathway and
enhancing IL-8 production by lung fibroblasts.
P7
Significant decrease of central venous catheter-associated
bloodstream infection rates in 38 German intensive care units
Sonja Hansen, Frank Schwab, Sandra Schneider, Dorit Sohr,
Christine Geffers, Petra Gastmeier
National Reference Center for Surveillance of Nosocomial
Infections, Institute of Hygiene, Charite – University Medicine
Berlin, Berlin, Germany
Critical Care 2008, 12(Suppl 5):P7 (doi: 10.1186/cc7040)
Background  Central venous catheter (CVC)-associated blood-
stream infections (BSI) remain a major complication in ICUs. The
aim of the study was to evaluate the influence of a structured
multimodal intervention programme on the CVC-BSI rate of 38
ICUs in Germany.
Methods ICUs of the ‘Krankenhaus Infektions Surveillance System’
showing a CVC-BSI rate above the median were asked to
implement a 12-month intervention programme starting in April
2007. The intervention included specific evidence-based recom-
mendations for CVC insertion and use, and involved nurses and
physicians. Modules were posters, script and advanced training.
The modules’ content was composed and distributed according to
the ‘train the trainer’ principle by the National Reference Center for
Surveillance of Nosocomial Infections. Infection rates were calcu-
lated before (January 2005 to June 2006) and during the inter-
vention (May 2007 to March 2008).
Results Thirty-eight ICUs participated in the study. The ICUs had a
median of 11 beds and eight ventilator beds. The majority of ICUs
(47%) were affiliated to teaching hospitals; 30% were affiliated to
university hospitals. The CVC utilization rate before implementation
of the intervention was 69.4 CVC-days per 100 patient-days. The
pooled mean CVC-BSI rate was 2.9 CVC-BSI per 1,000 CVC-
days. A preliminary analysis of the data obtained during the inter-
vention period showed a decrease of the mean CVC-BSI rate in
the participating ICUs (2.2 CVC-BSI per 1,000 CVC-days; relative
risk = 0.77, 95% confidence interval = 0.63 to 0.94, P = 0.011),
whereas the CVC utilization rate remained almost unchanged
(69.0 CVC-days per 100 patient-days).
Conclusion  A structured multimodal intervention programme in
addition to ongoing surveillance activities led to a significant
decrease of CVC-associated BSI rates.
P8
LightCycler SeptiFast assay as a tool for the rapid diagnosis
of sepsis in patients receiving antimicrobial therapy
Adriana Vince, Snjezana Zidovec Lepej, Bruno Barsic, Davorka
Dusek, Zdravko Mitrovic, Ranka Serventi Seiwerth, Boris Labar
Department of Molecular Diagnostics and Flow Cytometry,
University Hospital for Infectious Diseases ‘Dr. Fran Mihaljevic’,
Zagreb, Croatia
Critical Care 2008, 12(Suppl 5):P8 (doi: 10.1186/cc7041)
Background We analysed the clinical utility of the standardised,
Conformite Europeanne-certified, multiplex real-time PCR assay for
the molecular diagnostics of sepsis that was approved for in vitro
diagnostics use (LightCycler SeptiFast assay; Roche Diagnostics,
Pleasanton, CA, USA). The SeptiFast assay enables detection of
DNA from 25 human pathogens (Gram-positive and Gram-negative
bacteria as well as fungi).
Materials The study enrolled 50 patients with clinical diagnosis of
sepsis that received medical care at the University Hospital for
Infectious Diseases, Zagreb and Zagreb University Clinical Center
in Croatia. Ten patients were treated at the Department of Haema-
tology following bone marrow or peripheral blood stem cell
transplantation; 30 patients were hospitalised in the ICU and 10
patients outside the ICU. All patients enrolled in the study were
already receiving empirical antimicrobial therapy at the time of
testing.
Methods  Peripheral blood samples from the patients were
analysed using the LightCycler SeptiFast assay and cultivation.
Results Fifteen out of 50 (30%) samples tested positive with the
SeptiFast assay for bacterial or fungal DNA. Gram-negative bacteria
were detected in 13 of 15 samples (Klebsiella pneumoniae/
oxitoca, n = 6; Escherichia coli, n = 3; Pseudomonas aeruginosa,
n = 4). Gram-positive bacterial DNA (Enterococcus faecium, n = 1
and  Streptococcus pneumoniae,  n = 1) was detected in two
patients with polymicrobial sepsis (in combination with K.S4
pneumoniae/oxitoca in both patients). Aspergillus fumigatus DNA
was detected in two patients. Six out of 50 samples (12%) were
positive by both SeptiFast assay and culture. Additional SeptiFast-
positive results (negative by cultivation) were obtained in nine of 50
patients (18%). Four out of 50 samples (12%) tested negative by
the SeptiFast assay but were positive by culture. Those results
were interpreted as false negative molecular testing. The remaining
31 samples tested negative by both SeptiFast assay and culture. In
the group of 10 haematological patients, SeptiFast results were
positive for six of the 10 patients (60%), whereas blood cultures
were positive in only two out of 10 patients (20%).
Conclusion We conclude that the SeptiFast assay is a clinically
valuable add-on to conventional culture methods for rapid aetio-
logical diagnosis of sepsis in patients where the empirical
antimicrobial therapy has already been started and pretreatment
blood cultures were negative.
P9
Eosinophilia as a marker of adrenal insufficiency in critically ill
patients with severe septic shock: 1-year prospective study
Eleni Mouloudi, Constantine Katsanoulas, 
Dionysios Vrochides, Tatiana Giasnetsova, 
Chryssoula Papageorghiou, Nikoletta Gritsi-Gerogianni
Intensive Care Unit Department, Hippokrateion Hospital,
Thessaloniki, Greece
Critical Care 2008, 12(Suppl 5):P9 (doi: 10.1186/cc7042)
Background  Adequate adrenocortical function is essential to
survive critical illness. The number of circulating eosinophils has
been proposed as a marker of adrenocortical function. The goal of
the present study was to determine whether eosinophilia could
serve as a useful and early marker of adrenal insufficiency in
critically ill patients with severe septic shock.
Methods During a 1-year period, we studied prospectively all 294
patients admitted to our ICU. Sixteen patients (13 male/three
female, 5.4% of admissions) with eosinophilia defined as more
than 3% of the white blood cell count and severe septic shock,
refractory to fluid and vasopressor resuscitation, were included. A
high-dose (250 μg, intravenously) corticotropin stimulation test
was performed in all included patients.
Results  The mean age was 47.2 ± 18.7 years, the Acute
Physiology and Chronic Health Evaluation II score on admission
day was 18.6 ± 6.8 and the Sepsis-related Organ Failure
Assessment score was 10.3 ± 2.7 on eosinophilia day. The mean
eosinophil count was 6.9 ± 3.5% of white blood cells. Eosinophilia
was present 1.9 ± 0.9 days (range 8 hours to 4 days) before the
onset of septic shock. Multidrug-resistant Gram-negative bacteria
in 14 patients, Gram-positive in three patients and fungi in two
patients were isolated and considered responsible for sepsis.
Baseline cortisol levels were 19.4 ± 8.1 μg/dl and the adrenal
response to the corticotropin stimulation test was 8.3 ± 4.9 μg/dl
above baseline. Eleven out of 16 patients failed to respond to the
corticotropin stimulation test above the critical level of a 9 μg/dl
rise, and two out of 16 patients had baseline cortisol concentration
<10 μg/dl. A hydrocortisone infusion (300 mg/day) treatment
resulted in haemodynamic improvement in 12 out of 16 patients
(75%). The 28-day mortality (following the onset of septic shock)
was 43.7%. The only independent predictor of death was age
(P = 0.027).
Conclusion Relative eosinophilia may be considered a useful and
early bioassay for adrenocortical function assessment in critically ill
patients with severe septic shock and assumed adrenocortical
depression.
P10
Polymerase chain reaction detection of sepsis-inducing
pathogens in blood using SepsiTest™
Claudia Disqué1, Anna-Julia Kochem2, Helge Mühl1, 
Michael Lorenz1, Samir Sakka2
1Molzym GmbH & Co. KG, Bremen, Germany; 2Universität
Witten/Herdecke, Kliniken der Stadt Köln gGmbH, Krankenhaus
Merheim, Klinik für Anästhesiologie und Operative Intensivmedizin,
Köln, Germany
Critical Care 2008, 12(Suppl 5):P10 (doi: 10.1186/cc7043)
Background PCR enables the identification of bacterial DNA in
culture-negative samples from patients with suspected infection,
allowing the confirmation of, for example, meningitis and septic
arthritis. Gross discrepancies in the incidence of positive results
between culturing and PCR have been reported, the latter corres-
ponding better to bacterial loads observed by immunofluorescence
microscopy and inflammatory response measurements. The goals
of PCR assaying of clinical samples for pathogens are improved
disease surveillance, early guidance on appropriate antibiotic
therapy and patient management.
Methods  SepsiTest™ is a new PCR test for the presence of
bacterial and yeast pathogens in whole blood samples. The test
combines sample preparation, the directed extraction of pure
pathogen DNA from 1 ml blood, with PCR assays for the universal
detection of bacteria and yeasts based on the amplification and
monitoring of 16S and 18S rDNA sequences, respectively. Blood
from septic patients was extracted and analysed, using SepsiTest™
together with sequencing of amplicons from positive samples and
online BLASTN analysis for the identification of pathogens.
Results The test was validated by the determination of the limits of
detecting pathogens in blood (spiking experiments, >95%
sensitivity,  n = 6), including (colony-forming units/ml) Staphylo-
coccus epidermidis (20),  Staphylococcus aureus (40),  Strepto-
coccus pneumoniae (40), Escherichia faecalis (120), Escherichia
coli (150), Klebsiella pneumoniae (110), Enterobacter aerogenes
(210),  Pseudomonas aeruginosa (460) and Candida albicans
(400). In total, samples from 55 patients with systemic inflam-
matory response syndrome criteria were analysed in an ongoing
study. Compared with blood culturing, the preliminary data showed
a diagnostic sensitivity of 60%, specificity of 98%, negative
predictive value of 91% and positive predictive value of 86%.
Conclusion  The data are discussed with respect to the
significance of the molecular test for the diagnosis of sepsis.
Special emphasis is put on the clinical data available supporting
the finding of PCR-positive but culture-negative results.
P11
Impact of an educational program on the Surviving Sepsis
Campaign implementation for sepsis management
Pablo Perez d’Empaire, Juan Pal Otero, 
Stevens Salva Sutherland, Fernando Perez Barreto, 
Gabriel d’Empaire Yanes
Hospital de Clinicas Caracas Intensive Care Unit, Caracas,
Venezuela
Critical Care 2008, 12(Suppl 5):P11 (doi: 10.1186/cc7044)
Background  Severe sepsis and septic shock represent around
10% of the ICU admissions with a mortality rate near 50%. The
Surviving Sepsis Campaign (SSC) is an international quality
improvement program heading to standardize sepsis management.
Objective To evaluate an educational program to implement the
SSC strategies in our fourth-level hospital.
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Methods We implemented an educational program for physicians
and healthcare professionals to apply the SSC strategies in the
Emergency Department and the ICU. The program was evaluated
from May to October 2007 (Period 1) in terms of the compliance
of the SSC initial resuscitation bundle goals (lactate, blood
cultures, antibiotic administration, fluid administration, achieving
central venous pressure (CVP) >8 mmHg and central venous
oxygen saturation (ScvO2) >70%) and management bundle goals
(adhering to policy on corticosteroids and activated C protein
administration, glucose control <150 mg/dl, plateau pressure
≤30 cmH2O). The results were evaluated. Six months later the
program was repeated to reinforce the SSC concepts. The SSC
strategies implementation continued for the next 6 months and the
program was evaluated assessing the same indicators (Period 2).
The results from the two periods were compared.
Results Seventy-three consecutive subjects were included (36 in
Period 1 and 37 in Period 2). The demographic characteristics
were similar in both groups (Table 1). With the exception of blood
cultures (86.1% vs. 57.75%, P = 0.01), the initial resuscitation
bundle goals’ compliance was better achieved during Period 2;
lactate measured (66.66% vs. 89.18%, P = 0.02), antibiotics
administered within indicator timeline (50% vs. 75.67%, P = 0.03),
appropriate fluid administration (63.88% vs. 94.59%, P = 0.001),
when indicated achievement of CVP >8 mmHg (52.77% vs.
78.37%,  P = 0.02) and ScvO2 >70% (58.33% vs. 67.57%,
P = 0.47). With the exception of the activated C protein adminis-
tration policy (91.66% vs. 86.48%, P = 0.1), the management
bundle goals’ compliance was also better achieved during Period
2; corticosteroids according to policy (94.44% vs. 97.29%,
P = 0.61), glucose control <150 mg/dl (52.77% vs. 78.37%,
P = 0.02), plateau pressure ≤30 cmH2O (75% vs. 89.18%,
P = 0.13). In general we found a trend to better compliance in
resuscitation bundle goals (33.33% vs. 40.54%, P = 0.62) and
management bundle goals (63.88% vs. 67.56%, P = 0.80) during
Period 2 (Table 2).
Conclusion  An educational program and a retraining process
when linked with SSC implementation were effective in producing
process change in the management of severe sepsis, achieving
better compliance with currently accepted best practice.
P12
Automation of Septifast® for molecular diagnosis of infection
in septic patients
Benito Regueiro1, Eduardo Varela1, Lucia Martinez Lamas1,
Antonio Santos2, Julian Alvarez3
1Microbiologia, Hospital Clinico Universitario, Complejo
Hospitalario Universitario de Santiago, Universidad de Santiago,
Spain; 2Unidad Cuidados Intensivos, Hospital de Conxo, Complejo
Hospitalario Universitario de Santiago, Universidad de Santiago,
Spain; 3Anestesia y Reanimacion, Hospital Clinico Universitario,
Complejo Hospitalario Universitario de Santiago, Universidad de
Santiago, Spain
Critical Care 2008, 12(Suppl 5):P12 (doi: 10.1186/cc7045)
Background  Time is a critical issue in confirming infection in
systemic inflammatory response syndrome patients with suspected
sepsis. Early diagnosis, followed by prompt implementation of an
appropriate treatment, improves the prognosis of these patients.
The SeptiFast® test is a new multiplex PCR test for simultaneous
detection of sepsis-relevant microorganisms. It technically consists
of three well-defined phases: extraction, detection on the
LightCycler 2.0 machine and data analysis. The first one is a
manual procedure based on filtration that takes 3.5 to 4 hours. The
whole procedure including detection and data analysis takes
approximately 6 hours. The aim of our study was to automate the
current protocol using MagNa pure® compact and to evaluate the
potential advantages of reducing the time to perform the method.
Materials and study design Inclusion criteria were age ≥18 years
and suspected sepsis. The Ethics Committees from our institution
approved the study, and patient or relatives’ consent was obtained
for blood sampling for PCR. Patient population (ICU): 100
Septifast® determinations and correlative blood cultures and
microbiological cultures were performed in 64 patients with
systemic inflammatory response syndrome and high clinical risk
factors for bloodstream infection.
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Table 1 (abstract P11)
Demographic and clinical characteristics of patients
Period 1  Period 2 
(n = 36) (n = 37)
Age (mean (SD)) 67.63 (14.66) 65.48 (12.45)
Acute Physiology and Chronic  18.42 (14.66) 19.23 (12.08)
Health Evaluation II score 
(mean (SD))
Male sex (n (%)) 23 (62.16) 20 (50.05) 
Location at sepsis diagnosis (n (%))
Emergency department 17 (47.22%) 22 (59.45%)
Hospitalization wards 13 (36.11%) 6 (16.21%)
ICU 6 (16.21%) 9 (24.32%)
Type of sepsis (n (%))
Septic shock 8 (22.22%) 13 (35.13%)
Severe sepsis 28 (77.77%) 24 (64.86%)
Origin of infection (n (%))
Pneumonia 18 (50%) 19 (51.35%)
Abdominal infection 6 (16.66%) 11 (29.72)
Urinary tract infection 4 (11.11%) 5 (13.51%)
Catheter-related infection 3 (8.33%) 0
Soft-tissue infection 2 (5.55%) 1 (2.70%)
Others sites of infection 2 (5.55%) 1 (2.70%)
Meningitis 1 (2.77) 0
Table 2 (abstract P11)
Performance of sepsis bundle compliance
Period 1  Period 2  P
Measure (n = 36) (n = 37) value
Initial resuscitation bundle goals
Measure lactate 24 (66.66) 33 (89.18) 0.02
Blood cultures before antibiotics 31 (86.11) 21 (5.757) 0.01
Antibiotics within timeline 18 (50.0) 28 (75.67) 0.03
Fluid and vasopressors 23 (63.88) 35 (94.59) 0.001
CVP >8 mmHg 19 (52.77) 29 (78.37) 0.02
ScvO2 >70% 21 (58.33) 25 (67.56) 0.47
Management bundle goals
Low-dose corticosteroids policy 34 (94.44) 36 (97.29) 0.61
Activated protein C policy 33 (91.66) 32 (86.48) 0.1
Glucose control <150 mg/dl 19 (52.77) 29 (78.37) 0.02
Inspiratory plateau pressure  27 (75.0) 33 (89.18) 0.13
control
Initial resuscitation bundle completed 12 (33.33) 15 (40.54) 0.13
Management bundle completed 23 (63.88) 25 (67.56) 0.80
Data presented as n (%).S6
Methods We used a new multiplex PCR-based test, LightCycler®
SeptiFast® Test MGRADE (Roche Diagnostics, Penzberg,
Germany), including software for simultaneous detection of sepsis-
relevant microorganisms directly from blood, according to the
manufacturer’s recommendations. We followed the standard manu-
facturer’s recommended procedure for extraction and compared it
with the procedure using the MagNa pure® compact (Roche Applied
Science, Penzberg, Germany) extraction column based on magnetic
nanoparticles. Samples for blood culture analysis were drawn from a
fresh venipuncture site according to the common guidelines
(DGHM). Blood cultures were analyzed using a semi-automated
blood system (BacT/ALERT®; bioMerieux, Marcy-Etoile, France).
VITEK II (bioMerieux) was the system used to phenotypically identify
pathogens growing from blood cultures and other microbiological
tests (stool, urine, respiratory samples, catheter, etc.).
Results  The results were both retrospective and observational.
The quality of PCR results versus other laboratory findings and
clinical evaluation, using sensitivity and specificity analysis and
kappa evaluation to compare the results obtained, was determined.
One hundred determinations were studied comparing both
methods for extraction. Table 1 presents comparative data for both
methods. For sensitivity and specificity analysis, the blood culture
data define the disease condition (infection).
Conclusions  MagNa pure® extraction versus the standard
procedure for extraction used in the SeptiFast® test reduces the
total test time from 6 to 3 or 3.5 hours. Use of this alternative
protocol does not affect the sensitivity or specificity of the method.
Reference
1. Landis RJ, Koch GG: The measurement of observer agree-
ment for categorical data. Biometrics 1977, 33:159-174.
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Troponin can discriminate the most severe septic patients and
should be included as an early routine test in Surviving Sepsis
Campaign patients
Constantino José Fernandes1,2, Nelson Akamine1, Reinaldo
Salomão2, Luis Fernando Lisboa1, Otelo Rigatto2
1Hospital Israelita Albert Einstein, Sao Paulo, Brazil; 2Federal
University of Sao Paulo (UNIFESP), Sao Paulo, Brazil
Critical Care 2008, 12(Suppl 5):P13 (doi: 10.1186/cc7046)
Background  Myocardial injury can now be easily recognized in
critically ill septic patients and is associated with increased ICU
mortality. Troponin I is recognized nowadays as a highly sensitive
and specific serum marker of sepsis-induced myocardial injury/
depression and can predict outcome in the critical care setting.
Materials In order to confirm this prediction power we included
troponin I evaluations in our cohort of 100 patients within 24 hours
of admission to our institutional protocol with strict adherence to
the Surviving Sepsis Campaign guidelines within a tertiary care
hospital, therefore eliminating heterogeneous population bias.
Methods Cumulative survival curves were constructed using the
Kaplan–Meier method and were compared with the log-rank test.
Results were considered significant at P <0.05.
Results A total of 100 patients with severe sepsis/septic shock
met the inclusion criteria and were evaluated during the study
period. Demographic characteristics of the study population are
presented in Table 1. Except for age, which was slightly greater in
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Table 1 (abstract P12)
Comparative values of Septifast® (manual extraction) versus Septifast® (MagNa Pure® compact extraction)
Blood culture vs. Septifast® Blood culture vs. Septifast®
(manual extraction) (MagNa Pure® compact extraction)
Sensitivity 50 (27 to 72) 80 (56 to 94)
Specificity 98.75 (93 to 99) 95 (87 to 98)
Positive predictive value 90.9 (58 to 99) 80 (56 to 94)
Negative predictive value 88.76 (80 to 94) 95 (87 to 98)
Prevalence 20 20
Likelihood ratio positive test 40 (5.43 to 294.5) 15.99 (6 to 43.63)
Likelihood ratio negative test 0.506 (0.326 to 0.78) 0.21 (0.087 to 0.5)
Proportion agreement (strength of agreement) [1] 0.89 (moderate) 0.92 (substantial)
Bias index 0.09 0
Prevalence index –0.69 –0.6
Kappa (8) 0.586 0.75
Extraction volume 1,000 μl 400 μl
Time (extraction) 4 to 3.5 hours 25 to 30 minutes
95% confidence interval calculated with binomial expansion.
Figure 1 (abstract P13)
Kaplan–Mayer 28-day survival curves.S7
the positive troponin group, every other variable was not
significantly different, rendering the whole group very
homogeneous. Kaplan–Meier survival analysis within 28 days of
patient inclusion is shown in Figure 1 as stratified by troponin
positivity (>1.0 ng/ml). Troponin-positive patients showed
significant increased mortality with a log-rank value of 0.0072.
Conclusion The elevations of troponin observed were mostly small
to modest, reflecting minor cardiac injury, but they nonetheless
presaged increased mortality very early in the course of the
disease. Others have postulated that increased-troponin patients
can probably benefit most from drotrecogin-α administration with
mortality reduction, thereby rendering troponin determination
mandatory in critically ill septic patients. Troponin should therefore
probably be included as an early routine test in the Surviving
Sepsis Campaign.
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Pulmonary macrophage migration inhibitory factor: an
important contributor to age-dependent inflammation in
sepsis
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Yousef Al-Abed1, Kishorchandra Gohil2, Edmund Miller1
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Background Sepsis, the progressive, systemic host response to
infection, kills over 215,000 individuals annually in the United
States, and the mortality rate increases greatly with age. A recent
ICU survey of sepsis occurrence in acutely ill patients identified the
major site of infection as the lung (68%), Staphylococcus aureus
as the most common infecting agent (30%), and the median
patient age as 64 years. We therefore developed a rodent model
using S. aureus cell wall components lipoteichoic acid (LTA) and
peptidoglycan G (PGN) instilled into the lungs to study age-related
changes in pulmonary infection and sepsis.
Materials  Male Fischer 344 rats (Harlan Inc., Indianapolis, IN,
USA); C57Bl/6 mice, wild-type (mif+/+) and migration inhibitory
factor (MIF) gene-deficient (mif–/–) (Feinstein Institute for Medical
Research, Manhasset, NY, USA); LTA and PGN (Sigma-Aldrich
Co., St Louis, MO, USA); ELISA Assays (R&D Systems, Minnea-
polis, MN, USA); high-density oligonucleotide expression micro-
arrays (GeneChips; Affymetrix Inc., Santa Clara, CA, USA).
Methods  Saline alone (control) or LTA 1.5 mg/kg and PGN
5 mg/kg were instilled intratracheally into Fischer 344 rats 6, 18, or
24 months old (equating approximately to humans of 18, 45 and
60 years). After 6 hours, the animals were euthanized, blood
collected from the left atrium, and the lungs lavaged with saline
(bronchoalveolar lavage (BAL)). To further characterize the contri-
butions of MIF following LTA–PGN challenge, we used GeneChips
to obtain a description of the global transcriptomic response of
lungs from mif+/+ and mif–/– mice 6 hours post LTA–PGN.
Results  There were significant age-related increases in lung
compliance and BAL protein content (sham, 0.2 ± 0.01; 6 months,
1.2 ± 1.4; 18 months, 5.2 ± 0.7; 24 months, 4.8 ± 0.4 mg/ml),
suggesting a more severe injury in the older age groups. BAL
concentrations of GRO-KC (CXCL1) (sham, 0.13 ± 0.03; 6 months,
2.46 ± 0.79; 18 months, 2.89 ± 0.50; 24 months, 4.02 ± 1.54 ng/ml)
and IL-6 (sham, 0.1 ± 0.1; 6 months, 5.2 ± 5.6; 18 months,
14.2 ± 2.3; 24 months, 13.0 ± 6.8 ng/ml), and blood MIF concen-
trations around threefold higher in the older rats suggest an age-
dependent increase in inflammatory response. Comparative analysis
of lung transcriptomes (~8,500 mRNAs) of the mice suggested a
larger response in mif–/– mice of genes regulated by NFκB.
Conclusion These observations suggest, for the first time, a role
for MIF–NFκB molecular circuitry modulating cardiopulmonary
system responses following pulmonary infection. Since MIF can
cause cardiac dysfunction, the increased MIF response during
sepsis in the older individual may be responsible for an increased
mortality in this patient population.
Available online http://ccforum.com/supplements/12/S5
Table 1 (abstract P13)
Demographic and clinical features of the study population
Variable Troponin level n Mean Median P value
Acute Physiology and Chronic Health Evaluation II score All patients 98 25.20 25.00 0.2779
Negative 75 24.75 24.00
Positive 23 26.70 25.00
Age (years) All patients 100 72.37 77.00 0.0185
Negative 77 70.45 74.00
Positive 23 78.78 82.00
Organ dysfunctions All patients 100 2.91 3.00 0.6028
Negative 77 2.87 3.00
Positive 23 3.04 3.00
Mean arterial pressure (mmHg) All patients 62 60,03 58.17 0.5152
Negative 51 60.24 58.33
Positive 11 59.06 56.33
ICU length of stay (days) All patients 100 11.42 5.32 1.000
Negative 77 11.86 5.02
Positive 23 9.94 6.63
Lactate (mg/dl) All patients 96 34.95 27.00 0.6717
Negative 73 35.03 27.00
Positive 23 34.70 26.00S8
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Background Macrophage migration inhibitory factor (MIF) is a
proinflammatory cytokine and counter-regulator of glucocorticoids.
Since the 1990s, MIF has been known to be a critical mediator of
sepsis and septic shock. Circulating concentrations of MIF are
elevated in patients with sepsis, and MIF levels are associated with
disease severity and fatal outcome. Mouse monoclonal antibodies
and rabbit polyclonal antibodies against MIF were shown to be
protective in various animal models of sepsis. MIF therefore
emerged as an attractive new target for treatment of patients with
severe sepsis and septic shock.
Methods A diverse panel of human MIF-specific antibodies was
generated by selection from a phage display library. This panel was
subjected to extensive in vitro testing to identify antibodies that
neutralize MIF activity. The antibody showing the highest potential
was improved by affinity maturation; that is, by generating modified
versions of this antibody by CDR1-2 shuffling and selecting high-
affinity variants by phage display. The lead candidate antibody and
its affinity maturated variant were tested in experimental mouse
models of endotoxic shock and Escherichia coli peritonitis sepsis.
Results In vitro testing of human anti-MIF antibodies enabled the
identification of antibodies that neutralize the activity of MIF in a
glucocorticoid overriding activity assay and in a proliferation assay.
Antibody Bax94 was designated as lead candidate, and affinity
maturation of this antibody led to the generation of BaxA10, a
variant with a 10-fold higher affinity for MIF. In an endotoxic shock
model, pretreatment of mice with Bax94 and BaxA10 reduced
circulating concentrations of TNF (control antibody: 4.9 ± 10.3 ng/ml;
Bax94: 0.4 ± 0.4 ng/ml, P< 0.01; BaxA10: 0.2 ± 0.5 ng/ml,
P< 0.0001) and of IL-6 (control antibody: 3.1 ± 1.6 ng/ml; Bax94:
2.1 ± 0.78 ng/ml, P = 0.0003, Bax10: 1.5 ± 0.7 ng/ml, P< 0.0001),
and increased survival from 21% (control antibody) to 52%
(Bax94;  P< 0.05) and 58% (BaxA10; P< 0.05). The protective
effect of the two anti-MIF antibodies was also demonstrated in a
live E. coli peritonitis sepsis model in which survival rates increased
from 10% (control antibody) to 34% (Bax94; P <0.05) and to 56%
(BaxA10; P< 0.01).
Conclusion We have generated fully human anti-MIF antibodies that
neutralized the proinflammatory effects of MIF in vitro and that
showed significant protective effects in experimental sepsis. In vivo
protection tended to correlate with the affinity of the antibody for MIF.
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Background There is continuing concern regarding adverse renal
effects of colloid solutions in ICU patients.
Objective To compare two colloids, hydroxyethyl starch (HES 6%
130/.04) and gelatin 4%, on renal function in ICU patients.
Methods A before–after study of surgical ICU patients. Consecu-
tive patients admitted from January to June 2005 formed Group
HES, with HES as the standard colloid of choice. Patients admitted
from January to June 2006 formed Group GEL, with gelatin as the
primary colloid administered.
Results There were 1,383 patients in Group HES and 1,528 in
Group GEL; 118 and 87 patients, respectively, had severe sepsis.
There were some differences between groups in comorbidities and
surgical procedures for the patients overall; however, these
characteristics were more closely matched in the subset of severe
sepsis patients. The incidence of renal failure and the ICU and
hospital mortalities were similar in the two groups. In multivariate
analysis, cumulative doses >33 ml/kg of either HES (odds ratio =
1.85, 95% confidence interval = 1.01 to 3.41, P <0.001) or gelatin
(odds ratio = 1.99, 95% confidence interval = 1.05 to 3.79,
P = 0.035) were associated with higher risk of renal failure. In
severe sepsis, hospital mortality tended to be higher in Group HES
than in Group GEL (43% vs. 31%, P = 0.076). Patients with
severe sepsis who received a cumulative dose >33 ml/kg of either
colloid had a higher incidence of renal failure, which reached
statistical significance for the HES group.
Conclusion Moderate cumulative doses of modern HES or gelatin
solutions are associated with higher risk for acute renal failure.
These solutions should be used with caution, especially in severe
sepsis, until their safety can be demonstrated.
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Background Daily assessment of circulating immune/inflammatory
and organ function parameters is strongly advocated in septic
patients. In models of murine sepsis, such monitoring becomes
challenging given the limited blood volume available for analysis.
We studied the influence of daily versus single sampling in acutely
(days 1 to 5) septic mice upon their short/long-term survival, organ
function and complete blood count (CBC). We additionally tested
the reliability of CBC differential in resuspended cell pellet versus
whole blood analysis.
Methods Seventy-four female OF-1 mice (18 to 21 g body weight)
were subjected to cecal ligation and puncture (CLP). Blood
sampling volumes (by facial vein puncture) of 35 μl (n = 40) and
20 μl (n = 34) were tested. The samples were immediately diluted
1:10 to a final volume of either 350 μl (group 1) or 200 μl (group
2). Half of each group was sampled either daily for 5 days or only
on day 5 post CLP. For comparison of resuspended versus regular
CBCs, 150 μl (of the original 350 μl) was analyzed immediately
after sampling. The remaining 200 μl was then spun, plasma
removed (180 μl), the cell pellet re-suspended with an equal
volume of the diluent and CBC performed.
Results Repetitive daily bleeding, regardless of the volume, did not
affect either short-term (5 days) or long-term (28 days) CLP mor-
tality. By day 5, changes between groups in the level of circulating
IL-6, IL-1 receptor antagonist and organ function/metabolic
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parameters (ALT, LDH, glucose and urea) were identical. In group
1 (35 μl), the red blood cell (RBC) count was reduced by 22%
while the hemoglobin (Hb) concentration decreased by 23% (both
P <0.05). However, only a minimal decrease of RBC and Hb by
10% and 11%, respectively (both P <0.05), was observed in
group 2 (20 μl). In neither group were platelet or white blood cell
counts affected by repetitive bleeding. Except for lymphocytes, the
comparison of regular and resuspended CBCs displayed a high
correlation for all cell types (r >0.9, slope >0.9). On each post-
CLP day, the lymphocytes correlation remained moderate,
reaching r = 0.6 (slope = 0.6) on average (days 1 to 5). This effect
was reproduced when tested in non-CLP OF-1 mice (n = 12) at
1:2 dilution (r = 0.5, slope = 0.7).
Conclusion  Although we noted a statistically significant (and
inversely proportional) decrease in RBC and Hb after repetitive
daily bleeding, its biological impact was probably marginal.
Differential blood analysis in resuspended pellet was highly reliable
for all (except lymphocytes) cell populations tested. The results
indicate that low-volume daily blood sampling allows a multi-
directional and minimally invasive monitoring of various immuno-
inflammatory parameters in acutely septic mice.
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Background Patients with cirrhosis have higher risk of infection
and multiorgan dysfunction syndrome. Increasing evidence relates
them to the higher susceptibility to bacterial translocation (BT) by
liver dysfunction and hemodynamic changes. Herein, we evaluated
the role of BT in acute and chronic portal hypertension (a-PH and
c-PH) states without cirrhoses.
Methods Forty-eight Wistar rats were distributed in BT, a-PH, c-
PH with/without BT and control groups. a-PH (minimal shunting)
and c-PH (extensive shunting) were induced by calibrated portal
vein stenosis and were submitted to BT on days 2 and 14,
respectively, by oroduodenal inoculation (10 ml Escherichia coli
R-6, 107 or 1010 colony-forming units (CFU)/ml) and confinement
into the small bowel for 2 hours. BT-sham (saline), PH-sham
(without portal stenosis), and PH groups were monitored for
splachnic (liver, spleen, ileum) and kidney perfusion by laser
Doppler, and mesenteric lymph node (MLN), liver, spleen, lung,
blood and peritoneal fluid (PF) samples were cultured.
Results In the BT 1010 group, the culture was 100% positive at
the MLN, liver and spleen (5.3 and 3 log10 CFU/g, respectively),
while the blood, PF and lung were negative. In a-PH animals, the
BT 1010 pattern was 100% to the MLN, liver and spleen (5.4 and 4
log10 CFU/g, respectively), lung (100%, 3 log10, P <0.05) and PF
(10%, 0.6 log10). In turn, c-PH-BT1010 findings were similar to
BT1010 alone but there was an increased translocation to PF
(40%, 1 log10, P <0.05). On the other hand, for BT 107 all cultures
were negative, but in PH-BT107 translocation occurred to the MLN
(a-PH 50%, 1 log10 CFU/g; c-PH 25%, 0.7 log10 CFU/g) plus to
the PF (a-PH 12.5%, 0.08 log10 CFU/g; c-PH 25%, 0.16 log10
CFU/g), evidencing a change in the gut threshold for BT in the PH
state. Bacterial challenge in the a-PH state showed that the liver,
spleen and kidney go into a hypoperfusion state (–38, –45.2 and
–36  Δ%, respectively), in contrast to the ileum hyperperfusion
response (+75 Δ%). Similarly, at c-PH the liver and kidney
maintained a hypoperfusion state (–17%, –33% Δ%). Based on
both saline-PH groups’ data, however, the ileum and liver micro-
circulation functional adaptation was mostly compromised only at
the chronic phase.
Conclusion Portal hypertension factor without cirrhosis increases
and changes the pattern of BT, especially to the lung at a-PH and
to the PF at c-PH states, under small bowel Gram-negative
bacterial overgrowth conditions. These findings, in addition to the
tissue perfusion impairment, might explain the higher susceptibility
to infection in portal hypertension diseases.
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Background  The gastrointestinal tract has been implicated in
sepsis and organ failure by bacterial translocation (BT) and gut-
immune system crosstalk with the systemic immunity, but is not yet
clearly demonstrated in clinics. Herein we examined the role of gut-
associated lymphoid tissue on host inflammatory response by BT
as a contributing feature for multiorgan dysfunction in sepsis.
Methods Wistar rats were challenged to BT (10 ml Escherichia
coli R6, 1010 colony-forming units (CFU)/ml), sepsis (2 ml Entero-
bacter cloacae 89, 107 CFU/ml), and sepsis plus BT, with/without
mesenteric lymph flow interruption (MLFI) by canulation and lymph
deviation or by mesenteric lymphadenectomy plus lymph duct
ligation 5 days before in the following groups (n = 20/group): BT
(BT-G); BT with MLFI (BTL-G); sepsis (S-G); sepsis with MLFI
(SL-G); combination of BT to sepsis (C-G); combination with MLFI
(CL-G); sham-BT (SBT-G); sham-sepsis (SS-G); and sham-
combination (SC-G). Samples (mesenteric lymph node, blood,
spleen and liver) were collected 2 hours after and were cultured for
bacterial recovery of both sepsis and BT origin. Tissue perfusion
(jejunum, ileum, liver, kidneys) and mesenteric microcirculation
were monitored at 0 and 2 hours. Systemic blood and intestinal
lymph were collected for cell count and phenotyping. The groups’
mortality was followed.
Results The BT index was not modified by MLFI, but BT alone and
sepsis plus BT provoked significant hypoperfusion in all organs plus
microcirculation injuries. The MLFI at BTL-G and CL-G completely
abrogated tissue hypoperfusion (Figure 1) and microcirculation
injury. The lymph-cell count post BT, sepsis and combined challen-
ges was significantly increased compared with controls although
the composition was similar (98% to 99% lymphocytes and 1% to
2% others). The blood-leucocyte count was unchanged in all
groups (Figure 2). TCD3+ over B lymphocytes (CD45RA+) pre-
dominated in both lymph (83%/7%) and blood (68%/3%)
(P <0.05), and their percentages did not differ between groups. The
CD4+/CD8+ ratio also did not differ between groups. Naïve cells
(CD4+CD45RC+) predominated in the TCD4+ population in lymph,
and memory cells (CD4+CD45RC–) in blood. CD8+CD45RC+ cells
predominated in both lymph and blood. The proportion of T-
regulatory (CD4+CD8+/CD25+) cells was low in both lymph and
blood for all groups (Figures 3 and 4). MLFI completely prevented
the death observed in C-G (LD50).
Conclusion The gut-associated lymphoid tissue response follow-
ing bacterial challenge and its crosstalk with the systemic immunity
Available online http://ccforum.com/supplements/12/S5S10
via the lymphatic system is the key factor related to the aggravation
of systemic inflammation and death in sepsis.
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Background Some of the enteric microbiota role is linked to the
gut immune system, the angiogenic mechanism and colonization
resistance, and its disruption has been correlated to local disease
and aggravation of a systemic inflammatory state such as in sepsis
and critical illness. Herein we examined the role of diverse sepsis
intensities on aerobic and anaerobic facultative Gram-negative
microbiota of the small bowel (SB) and large bowel (LB) and
subsequent bacterial translocation (BT) potentials in rats.
Methods Wistar rats (±200 g) were submitted to varying degrees
of monobacterial sepsis (S-7, S-8 and S-9 groups, with 107, 108
and 109 colony-forming units/ml/100 g body weight of Escherichia
coli R6 intravenously, respectively) and samples of the duodenum,
jejunum, ileum, cecum, feces, mesenteric lymph nodes (MLN), liver
and spleen were harvested at 6, 12 and 24 hours post sepsis and
cultured in MacConkey agar medium (n = 6/period/group). Control
groups were sham with saline injection and naïve without any
procedure (n = 6/period/group).
Results  The Gram-negative colonization rise within the SB
occurred from the proximal to distal compartments and significant
overgrowth onset was seen from 6 hours in the SB and 12 hours
in the LB in the sepsis groups, suggesting that LB overgrowth was
probably due to SB overgrowth. With severe sepsis (S-8, S-9), the
overgrowth was more pronounced and remained for a longer
period at the ileum and cecum, but at the duodenum and jejunum
the peak growth seen in the 6 to 12 hours period returned to
normal level at 24 hours. The maximum overgrowth index com-
parisons between naïve, S-8 and S-9 were (log10): 0.0 versus 2.8
versus 4.7 (duodenum), 2.5 versus 4.2 versus 6.0 (jejunum), 4.0
versus 7.4 versus 7.5 (ileum), and 5.1 versus 8.0 versus 7.8
(cecum), respectively. Spontaneous BT to the MLN occurred only
following sepsis (50% at S-8, 5.6% at both S-7 and S-9) and was
100% E. coli. Not only E. coli but all other Gram-negatives were
overgrown after sepsis stimulus. S-7 and minor trauma (sham)
provoked a transient overgrowth but in lesser intensity and
endurance.
Conclusion  Acute sepsis states induced a significant and
transient SB and LB Gram-negative microbiota overgrowth directly
proportional to the severity of sepsis. The BT event was dependent
on both the sepsis degree and overgrowth factors.
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Figure 2 (abstract P19)
Total number of leukocytes in the mesenteric lymph and blood per
mm3 of all groups. *P <0.05.
Figure 1 (abstract P19)
Comparison of the tissue perfusion (jejunum, ileum, liver and kidneys)
in Δ% and the mortality index (DL) in all groups. *P <0.05.
Figure 3 (abstract P19)
CD4-positive T-cell subsets (N, naïve; M, memory; and Reg, regulatory)
in the mesenteric lymph and blood of all groups by flow cytometry. 
Figure 4 (abstract P19)
CD8-positive T-cell subsets (N, naïve; M, memory; and Reg, regulatory)
in the mesenteric lymph and blood of all groups by flow cytometry.S11
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Background  The PROWESS study and later trials of activated
protein C (APC) treatment in sepsis have shown only modest
reductions in mortality. A recent Cochrane systematic review
(CD004388) records doubtful efficacy and serious adverse
effects. To optimize the benefit/risk ratio of APC treatment of each
patient, a biomarker of protein C (PC) activation is urgently needed
and the use of such a marker, activated protein C–protein C
inhibitor (APC–PCI), has been investigated in the present study.
Methods  APC–PCI was measured in acid citrate plasma by
means of a newly developed sandwich ELISA (median normal
value 0.13 ng/ml, range 0.07 to 0.26, n = 16). Levels of APC–PCI
and PC were monitored (daily to alternate days) in 135 consecu-
tive critically ill patients, 53 of whom had sepsis during the obser-
vation period. The state of PC activation to APC was categorized
as nonactivated, moderately activated or highly activated, based on
maximum APC–PCI values in relation to the normal range.
Results The maximum APC–PCI values were 0.03 to 29 ng/ml,
median 0.44 ng/ml. The overall mortality of the 53 sepsis patients
was 32% (17/53). The mortality and relative mortality (mortality of
activation group/overall mortality) of each activation group are
presented in Table 1. A bell-shaped mortality relationship was
noted, with high mortalities in both the nonactivated and highly
activated groups. Notably, the lowest mortality was recorded in the
moderately activated group. Subdividing activation groups by the
Acute Physiology and Chronic Health Evaluation (APACHE) II
score yielded the highest mortality (5/7 = 71%, relative mortality
227.7%) in the nonactivated subgroup with APACHE II score ≥25,
whereas the APACHE II score did not influence mortality in the
other activation groups. Minimum PC levels did not correlate with
APC–PCI and showed no significant differences between the
activation groups.
Conclusion  Nonactivation of PC in sepsis may represent the
failure of an appropriate protective response and is therefore
associated with increased mortality, especially when the APACHE
II score is elevated. Septic patients without PC activation and a
high APACHE II score may be those who are most likely to benefit
from APC treatment. PC measurements were not predictive of PC
activation as indicated by APC–PCI levels.
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Background  The intestinal hypothesis of sepsis has been
attributed to bacterial translocation (BT) and the aggravation of
sepsis is related to the increased vascular permeability state that
potentates the BT index. In the present study we examined the BT
index during sepsis with or without mesenteric lymph exclusion.
Methods Wistar rats (±200 g) were submitted to the BT process
(Escherichia coli R6, 10 ml of 1010 colony-forming units (CFU)/ml)
and nonlethal sepsis (Escherichia cloacae 89, 2 ml of 107 CFU/ml)
plus BT, with or without mesenteric lymph interruption by
mesenteric lymph node resection and lymph duct ligature 5 days
prior to the experiments. Samples (blood, spleen and liver) were
collected 2 hours after the inoculation and were cultured to recover
bacteria of intestinal origin. One-half of the animals/group was
observed to the mortality index. The groups (n = 20/group) were:
BT group (BT-G); BT with lymphadenectomy (BTL-G); combination
(C-G); and combination with lymphadenectomy (CL-G).
Results BT was 100% positive in all groups. The BT index was
similar between BT-G, BTL-G and CL-G (P = 0.6) and mortality
was not observed in these groups, although a considerable
amount of translocated bacteria could be recovered, particularly at
the liver and spleen (Figure 1). When BT was added to the sepsis
without lymph exclusion (C-G) the BT index was statistically lower
(P = 0.04), but 50% (LD50) of mortality occurred within 30 hours
(Figure 1).
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Table 1 (abstract P21)
Mortality and relative mortality (mortality of activation group/overall mortality) of each activation group
PC activation group
Nonactivated,  Moderately activated,  Highly activated, 
APC–PCI <0.25 ng/ml APC–PCI 0.25 to 0.72 ng/ml APC–PCI >0.72 ng/ml
Mortality Relative mortality Mortality Relative mortality Mortality Relative mortality P value (χ2)
Sepsis mortality (deaths/n) 43.8% (7/16) 136.4% 13.0% (3/23) 40.7% 50.0% (7/14) 155.9% 0.032
Figure 1 (abstract P22)S12
Conclusion These results showed that, more than the amount of
translocated bacteria, the gut-associated lymphoid system
activation by the BT process played a pivotal role in the worsening
of sepsis. Besides, BT occurred independently of mesenteric
lymph interruption, showing that the hematological pathway of BT
might be the principal route for bacterial dissemination into the
bloodstream.
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Background Methicillin-resistant Staphylococcus aureus (MRSA)-
induced sepsis/septic shock is a major cause of death in the ICU.
We have previously reported that excessive nitric oxide (NO) plays
a key role in impaired cardiovascular function during MRSA sepsis.
In the present study, we demonstrate a role of inducible (iNOS)
and neuronal (nNOS) nitric oxide synthase-derived excessive NO
in MRSA-induced cardiovascular morbidity using potent and
selective iNOS dimerization inhibitor BBS-2 and selective nNOS
inhibitor 7-nitroindazole (7-NI).
Methods Ewes were operatively prepared and randomized after a
5-day to 7-day recovery period to the groups: sham (noninjured,
nontreated,  n = 6); control (injured, nontreated, n = 6); BBS-2
(injured, treated with BBS-2, n = 5); and 7-NI (injured, treated with
7-NI, n = 3). Injury consisted of insufflation of 48 breaths of cotton
smoke followed by instillation of 2 to 5 x 1011 colony-forming units
of live MRSA into the airways of the sheep. BBS-2 (100 μg/kg/hour)
and 7-NI (1 mg/kg/hour) was given starting from 1 hour to the end
of the study (24 hours).
Results  Hemodynamic variables were stable in sham animals.
Control sheep developed a hyperdynamic circulatory state as
evidenced by a significant increase in cardiac output and a severe
fall in mean arterial pressure (Table 1). BBS-2 significantly
attenuated hypotension 12 and 18 hours (P <0.05) post injury. In
contrary, 7-NI reversed the fall in blood pressure at a later time
point. Severe fluid retention seen in control animals was reduced
by 7-NI, but not by BBS-2. 7-NI also improved oxygenation.
Elevated levels of heart tissue 3-nitrotyrosine (marker of peroxy-
nitrite formation) and poly (ADP)ribose (footprint of DNA damage)
were attenuated by both iNOS and nNOS inhibition.
Conclusion iNOS inhibition had a partial effect in MRSA sepsis-
related cardiovascular morbidity. However, nNOS inhibition had a
stronger effect on both severe hypotension and fluid retention
following MRSA sepsis. Since nonspecific NOS inhibition is
associated with unwanted side effects, more targeted inhibition of
NO using specific NOS inhibitors may be a useful tool against the
MRSA sepsis-related menace.
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Background  Increasing bacterial antibiotic resistance combined
with the increasing incidence of Clostridium difficile disease
complicate the choice of empirical therapy for ventilator-associated
pneumonia (VAP). Etest strips rapidly adsorb a gradient of
antimicrobial agent onto agar, allowing determination of minimum
inhibitory concentration of cultured organisms. Their use on plates
directly inoculated with respiratory samples to provide rapid
susceptibility results in VAP has previously been described in a
study in which the principal pathogens were Staphylococcus
aureus and Pseudomonas aeruginosa. The current study evaluated
the technique in a setting where resistant Enterobacteriaceae
predominate.
Methods Chromogenic Mueller–Hinton agar was inoculated with
100 respiratory specimens from patients clinically suspected to
have VAP. Vancomycin, cefoxitin, cefotaxime, ceftazidime,
piperacillin–tazobactam and meropenem Etest strips were then
applied to the inoculated medium strips selected to aid detection
of resistant Gram-negative pathogens. In addition, a P. aeruginosa
diatab was applied to plates to facilitate identification of this
organism. The plates were incubated at 37°C in 5% CO2 overnight
and subsequently interpreted using a prospectively designed
protocol to suggest antimicrobial choice. Specimens were
processed using UK standard methods in parallel to allow
comparison of speed and accuracy.
Results  Forty-four out of 100 samples yielded no significant
bacterial growth using the standard method. Sixty-three isolates
were speciated from the remaining 56 samples (including 37
coliforms and 13 P. aeruginosa). Fifty-four of these samples had
detectable growth at day 1 by the Etest method. Of the coliforms,
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Table 1 (abstract P23)
Hemodynamic variables
Sham Control BBS-2 7-NI
Cardiac output (l/min)
Baseline 4.6 ± 0.4  5.2 ± 0.3 4.9 ± 0.2 5.8 ± 0.1
24 hours 4.1 ± 0.3 9.2 ± 0.6 8.5 ± 0.6 7.4 ± 0.8
Mean arterial pressure (mmHg)
Baseline 99 ± 1 92 ± 2 102 ± 3 98 ± 1
24 hours 100 ± 1 70 ± 1 71 ± 2 93 ± 1
Fluid retention at 24 hours (ml/kg) 0.0 ± 5.9 282 ± 17 293.0 ± 6.0 177.6 ± 58.3
PaO2/FiO2
Baseline 563 ± 19 520 ± 30 480 ± 14 547 ± 15
24 hours 619 ± 7 176 ± 68 157 ± 93 212 ± 82S13
17 possessed extended-spectrum β-lactamase genes, including
ampC, all detected by the Etest method. Organisms were
confirmed susceptible to the Etest suggested antibiotic in 52/54
cases. Direct results would have led to a change in antibiotics to a
more appropriate agent in 11 cases. An early indication of the
presence of a multiresistant pathogen would have occurred in four
cases. All Etest results were available within 24 hours, compared
with a mean time to sensitivity reporting of 2.25 days using the
standard method.
Conclusion The direct Etest method provides rapid and accurate
susceptibility results on patients with VAP, expediting selection of
an antibiotic of appropriate spectrum.
P25
Evaluation of an agar-gradient minimum-inhibitory-
concentration method (the Etest) as a rapid and direct
measure of antimicrobial susceptibility in Gram-negative
bacteraemia
Tom Darton, David Partridge, Steve Davis, Rob Townsend
University of Sheffield, School of Biomedical Sciences and
Sheffield Teaching Hospitals NHS Foundation Trust, Department of
Medical Microbiology, Sheffield, UK
Critical Care 2008, 12(Suppl 5):P25 (doi: 10.1186/cc7058)
Background  The selection of appropriate antibiotics to treat
Gram-negative bacteraemia may be life-saving. Rapid methods of
antimicrobial susceptibility testing have sought to guide early
antibiotic selection and usage. We sought to evaluate whether a
combination of chromogenic agar and six Etest gradient diffusion
strips could be used to provide a clinically useful, direct rapid anti-
microbial susceptibility test result following 4 hours of incubation.
Methods Fifty consecutive Gram-negative blood culture isolates
were tested over a 4-month period. Following confirmation of
Gram-negative bacilli, 200 μl blood was directly inoculated from
the enrichment broth onto a chromogenic MH agar plate. Six Etest
strips were directly applied onto the agar using an automated
placement device (Simplex C76; Inverness Medical UK (Bio-Stat
Division), Stockport, UK). The antibiotics used were cefoxitin,
cefotaxime and ceftazidime (to indicate the presence of extended-
spectrum and ampC β-lactamase producers), vancomycin (to
‘screen’ for Gram-positive organisms), and piperacillin–tazobactam
and meropenem (based on local prescribing patterns). The plates
were incubated at 35 to 37ºC and read at 4, 6 and 24 hours.
Minimum-inhibitory concentration values were determined and
organisms were categorized as susceptible/resistant according to
British Society for Antimicrobial Chemotherapy breakpoints. A
presumptive identification and susceptibility profile was obtained at
4 hours, based upon which the investigators recorded a decision
as to whether the patients’ antibiotics could be escalated, de-
escalated or remain unchanged. The results were correlated with
those at 6 and 24 hours, and with the report issued following
routine susceptibility testing, as performed at our institution.
Results Forty-five (90%) cultures had Etest susceptibility profiles
interpretable at 4 hours. Of the five remaining, three (6%) were
read at 6 hours and two (4%) at 24 hours. In three cases there
was a mixed growth of organisms. Twelve (24%) organisms had
resistance mechanisms identified, of which 10 (83%) were
confirmed by our routine antimicrobial susceptibility rest method.
At 4 hours, nine (18%) patients were receiving too narrow spec-
trum antibiotics. Additionally, the investigators felt that antibiotics
could have been safely de-escalated in 16 (32%) cases and
continued in the remaining 25 (50%) patients.
Conclusion Our evaluation of this method has shown that it can
provide rapid and reliable antibiotic susceptibility information at
4 hours. This could potentially have a major impact on antibiotic
use and may significantly affect patient management.
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Background Statins have a well-known pleiotrophic effect as anti-
inflammatory agents, immunomodulators, antioxidants, antithrombotic
agents and endothelial stabilizers. Statins, however, have been
proposed as a therapeutic tool in septic patients.
Objective To investigate possible statin therapeutic uses in the
induced sepsis inflammatory process.
Methods  A prospective, longitudinal, experimental study was
performed from November 2007 to March 2008 of 40 consecutive
septic patients who were randomly assigned to one of the following
groups: treatment group (received 80 mg daily simvastatin for 14
days) or control group (did not receive simvastatin). Inflammatory
markers (sedimentation rate (SR), C-reactive protein (CRP), and
antitrombin III) were measured on days 0, 5, 10 and 14. Results are
expressed as the median (25th–75th interquartile interval) and
groups were compared with the Mann–Whitney U test. 
Results The SR diminished from 34 (21 to 45) to 19 (14 to 23) in
the treatment group, versus the control group where it increased
from 28 (21 to 40) to 36 (27 to 50), with P <0.01 when both
groups were compared. CRP behaved in a similar way, diminishing
in the treatment group and increasing  in the control group. On day
14, the SR and CRP reached normal values: 4 (2 to 6) and 1 (0 to
2), respectively, in the treatment group versus 22 (19 to 36) and 8
(4 to 14), respectively, in the control group (P <0.001). Anti-
thrombin III increased in both groups, from 33 (28 to 50) to 90 (88
to 98) in the treatment group and from 33 (29 to 50) to 50 (48 to
55) in the control group (P <0.01). The length of stay was longer in
the control group: 22 (18 to 26) days versus 15 (14 to 16) days in
the treatment group (P <0.01).
Conclusion The present study demonstrates that statins are able
to decrease the systemic inflammatory response and provide
endothelial increased stability properties from the fifth treatment
day; reducing the mechanical ventilation time rates, and so on, with
the patient’s long stay.
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Background  During the course of a bacterial infection, a rapid
identification of causative agents is necessary for the determination
of effective treatment options. We developed a method based on a
modified broad-range PCR and an oligonucleotide microarray for
the simultaneous detection and identification of 19 sepsis-causing
pathogens at species level, as well as coagulase-negative staphylo-
cocci and Enterobacteriaceae at taxon level.
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Materials  One hundred and fifty-four positive and 15 negative
blood culture samples were collected to evaluate the assay
performance. For the analysis, DNA was automatically extracted
from the samples.
Methods  The broad-range PCR primer mixture was designed
using conservative regions of topoisomerase gene subunits gyrB
and ign from various bacteria. The primer design allowed the use of
a novel DNA amplification method producing labeled, single-
stranded DNA suitable for microarray hybridization. The probes on
the microarray were designed against species-specific or taxon-
specific variable regions of the gyrB and ign genes flanked by the
primers. As a microarray platform for the probes, we applied
TubeArray that is a microreaction vial containing a microarray at the
bottom. To indicate the detection of antimicrobial resistance, we
included  mecA-specific primers and probes in the same assay.
Furthermore, the software for automated data analysis was provided.
Results Comparison of the assay results with the gold standard
culturing method revealed sensitivity of 98% and specificity of
93%. When the mecA identification was correlated with Staphylo-
coccus aureus, Staphylococcus epidermidis, and Staphylococcus
genus detection by the specific probes, accurate information about
the association of the mecA gene with staphylococci was
provided. The results from these 15 samples were in line with the
antimicrobial susceptibility testing (oxacillin susceptibility testing).
Conclusion The results from the method were available 3 hours
after the positive blood culture result. Up to 24 samples could be
processed simultaneously. The assay therefore provides rapid and
reliable data, which can guide antimicrobial treatment decisions in
a timely manner. We have further broadened the pathogen panel
for the detection of 50 bacterial species; 24 at the species level
and at least 26 species at the taxon level. The described panel is
now commercially available from Mobidiag Ltd (Helsinki, Finland)
under the product name Prove-it™ Bacteria.
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Background  Septic shock is associated with severe cardiac
dysfunction, whose mechanisms remain partly undefined. Recent
data suggested that it might be triggered by the direct action of
microorganisms and their products on the heart itself. We
previously showed that flagellin, the protein monomer from bacterial
flagella, is a potent activator of NFκB-dependent proinflammatory
signaling in cultured cardiomyocytes. In the present study, we
investigated whether flagellin might induce such an inflammation in
the heart in vivo and contribute to cardiac dysfunction.
Methods Mice were injected intravenously with 1 μg flagellin. At
selected timepoints (30 minutes to 4 hours), the effects of flagellin
were evaluated by its ability to activate NFκB, mitogen-activated
protein kinases and downstream signaling. Expression of the
flagellin receptor TLR5 was also investigated. Cardiac function
was evaluated after 4 hours using a microtip pressure–volume
catheter inserted into the left ventricle. Also, human cardiac tissue
was obtained from the right atrium in patients undergoing elective
coronary artery bypass grafting surgery, to determine the presence
of TLR5 in the human heart.
Results Cultured cardiomyocytes, as well as hearts from mice and
humans, expressed TLR5 protein at a high level. Flagellin activated
NFκB and the mitogen-activated protein kinases p38 and JNK in
cardiomyocytes  in vitro and  in vivo, and also upregulated the
transcription of TNFα and MIP-2. In vivo, flagellin also induced the
recruitment of neutrophils within the heart. Functionally, flagellin
induced significant increases in end-systolic and end-diastolic left
ventricle volumes, indicating cardiac dilation, and a significant
reduction of end-systolic elastance and maximal elastance, indicating
depressed myocardial contractility. In contrast, no change in the
slope of the end-diastolic pressure–volume relationship was noted.
Conclusion Bacterial flagellin induces a prototypical inflammatory
response in cardiomyocytes in vitro and in the myocardium in vivo.
These effects are associated with a profound alteration of the left
ventricle systolic function in vivo, suggesting that flagellin may
represent a critical mediator of cardiac dysfunction in septic shock.
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Background Impaired cardiac function due to reduced myocardial
contractility is a typical manifestation of septic shock, whose
mechanisms are poorly defined. Experimentally, the administration
of endotoxin (lipopolysaccharide (LPS)) to laboratory animals is
classically used to study the mechanisms of septic cardiomyo-
pathy. However, most studies evaluating the effects of LPS on the
heart in vivo have relied on indirect, load-dependent, indices of
cardiac function, and thus could not precisely determine the real
consequences of LPS on cardiac contractility. We therefore
evaluated the direct effects of LPS on cardiac contractility in mice,
using left ventricular (LV) micro-tip pressure–volume (PV) catheters,
which provide load-independent measurements of cardiac function,
including end-systolic elastance (Ees) and maximal elastance (Emax).
Methods Male BALB/c mice received an intraperitoneal injection
of  Escherichia coli LPS (1, 5, 10, or 20 mg/kg). After 2, 6 or
20 hours, selected groups of mice were anesthetized, intubated
and mechanically ventilated. A PV catheter was inserted into the
left ventricle through the right carotid artery. LV pressure (end
systolic (LVSP) and end-diastolic (LVDP)) and volumes (end
systolic (ESV) and end-diastolic (EDV)) were recorded, allowing
the calculation of the stroke volume, stroke work, cardiac output
and ejection fraction. Ees and Emax were computed from the slope
of the end-systolic PV relationships of successive PV loops
obtained at rapidly reduced preload, by inferior vena cava
compression. Mice were sacrificed at the end of the experiments.
Results EDV decreased with LPS, mostly after 6 hours, whereas
ESV did not change. LVSP was slightly decreased only after 6
hours, and LVDP was not significantly influenced by LPS. The
stroke volume, stroke work, ejection fraction and dp/dtmax were
reduced at all doses of LPS, mostly after 6 hours and slightly
recovered after 20 hours. In spite of an increase in heart rate, the
cardiac output decreased, especially after 6 hours and at the high
doses (10 and 20 mg/kg) of LPS. Most importantly, both Ees and
Emax markedly increased after all doses of LPS, mostly after 2 and
6 hours, and returned back to control values after 20 hours.
Conclusion In striking contrast with the usual belief, LPS does not
induce direct negative inotropic effects in the mouse, but instead
markedly enhances contractility. The alterations in cardiac function
induced by LPS are only, and entirely, due to altered loading
conditions, which are mainly observed 6 hours after the injection of
LPS.
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Background The development of septic shock is related to the
activation of nonspecific (innate) immune responses, triggered by
the interactions between molecules released by pathogens and
specific cellular receptors in the host, termed Toll-like receptors
(TLRs). Flagellin is a 55 kDa protein isolated from the flagellum of
Gram-negative bacteria, which may activate such responses
through its recognition by TLR5. The tissue distribution of TLR5, as
well as the actions of flagellin on various organs in vivo, has not
been previously established. We therefore conducted the present
study to determine the presence of TLR5 receptor in major organs
from mice, and to evaluate whether flagellin could trigger
prototypical innate immune responses through activation of NFκB
and mitogen-activated protein kinase (MAPK) signaling pathways
in these organs.
Methods Mice were injected intravenously with 1 μg recombinant
Salmonella flagellin. At selected timepoints (30 minutes to 6 hours),
the mice were sacrificed and the major organs (lung, liver, gut and
kidney) were harvested for expression of the flagellin receptor
TLR5; for the activation state of NFκB (monitored by the degree of
phosphorylation and degradation of its inhibitor IκBα and by the
NFκB-DNA-binding activity); for the activation state of MAPK
(monitored by the degree of phosphorylation of JNK, p38 and
ERK); for the expression of inflammatory cytokines; and for the
activation of apoptotic pathways (monitored by the degree of
caspase-3 and poly(ADP-ribose) polymerase cleavage). Plasma
was obtained for the measurements of cytokine levels.
Results TLR5 protein was constitutively expressed in all organs.
The injection of flagellin activated NFκB and MAPKs at 30 minutes,
and markedly enhanced the generation of the cytokines TNFα,
IL-1β, IL-6, TREM-1, and MIP-2 at 1 hour and 3 hours. Similarly,
these cytokines significantly increased in the plasma from 1 hour to
6 hours after flagellin. Flagellin also triggered prototypical apop-
totic changes in all organs.
Conclusion Bacterial flagellin activates inflammatory signaling and
apoptosis in most major organs in vivo, and thus may represent a
critical mediator of multiple organ failure during Gram-negative
septic shock.
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Background Acute kidney injury (AKI) occurs in about one-half of
the patients who develop septic shock, and the mortality of AKI
with sepsis is extremely high. An effective therapeutic intervention
is urgently needed. In the present study we tested the ability of a
novel tetrapeptide, EA-230, to improve survival and attenuate loss
of kidney function in a clinically relevant model of sepsis – cecal
ligation and puncture (CLP) in mice.
Methods Sepsis was induced in C57BL/6 mice by CLP. Four hours
postoperatively, EA-230 was administered. Subsequently, animals
were treated twice daily for four consecutive days intraperitoneally.
The effects of 20, 30, 40, or 50 mg/kg were compared with those of
saline. Survival and renal function were monitored. Inulin clearance
and para-aminohippuric acid clearance were used to measure the
glomerular filtration rate and renal blood flow.
Results  All saline-treated control animals died within 5 days of
CLP, whereas EA-230 treatment improved survival significantly in a
dose-dependent manner. The best result was obtained with
50 mg/kg EA-230 (43.8% survival after 2 weeks). Serum creatinine
and blood urea nitrogen increased markedly 24 hours after CLP.
EA-230 attenuated the increases in creatinine and blood urea
nitrogen significantly in the 30 to 50 mg/kg treatment groups.
Furthermore, the glomerular filtration rate and renal blood flow
were significantly higher (P <0.05) 36 hours post CLP in EA-230-
treated mice versus those treated with saline.
Conclusion EA-230 is a novel and promising therapeutic agent for
preventing AKI in sepsis. Its beneficial effect is associated with an
improvement in renal hemodynamics.
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Background Early diagnosis, antibiotics and supportive therapy are
essential in sepsis. The diagnostic value of clinical and laboratory
variables was evaluated in a prospective observational study.
Methods  A cohort of 404 adult patients admitted to the
Department of Infectious Diseases from the emergency room for
suspected severe infection was studied. A bacterial infection
requiring antibiotic treatment was diagnosed in 306 patients
(pneumonia 130 patients, urinary tract infection 80 patients,
skin/soft tissue 43 patients, other bacterial infections 53 patients)
and bacteriemia in 68 patients (most common isolates: pneumo-
cocci 19 patients, Escherichia coli 18 patients, Staphylococcus
aureus eight patients, β-haemolytic streptococci seven patients).
Nonbacterial infections or noninfectious conditions were diag-
nosed in 82 patients. The physiological variables recorded were:
temperature, heart rate, blood pressure, respiratory rate (RR),
oxygen saturation, urine output, and cerebral status. The laboratory
variables were: C-reactive protein (CRP), lactate, bicarbonate,
creatinine, urea, hemoglobin, white blood cells (WBC), neutrophils,
platelets, International Normalized Ratio, D-dimer, albumin,
bilirubin, procalcitonin (PCT), IL-6 and lipopolysaccharide binding
protein (LBP).
Results In a univariate analysis, PCT, IL-6, LBP, CRP, bilirubin and
maximum RR during the first 4 hours (RR max 0 to 4 hours) were
associated with bacteremia with P <0.001 and CRP, PCT, IL-6,
LBP, WBC, neutrophils, RR max 0 to 4 hours and hemoglobin
were associated with a bacterial infection with P <0.001. In a
multivariate logistic regression, PCT, RR max 0 to 4 hours, bilirubin
and CRP each contributed significantly to the accurate prediction
of bacteremia. To predict a bacterial infection, CRP, WBC,
hemoglobin and RR max 0 to 4 hours contributed significantly. The
diagnostic accuracy of these variables was compared with the
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ability of the physicians caring for the patients to prescribe
antibiotics appropriately. Of the 306 patients with bacterial
infections requiring antibiotics, 76% had actually received
antibiotics within 4 hours of arrival; and of the patients not requiring
antibiotics, 54% were not on antibiotics after 4 hours. All variables
tested had inferior diagnostic accuracy compared with the
clinician.
Conclusion  We conclude that for the clinician, who evaluates
patients with a suspected infection, special attention should be
directed to the RR, CRP and WBC but the basic evaluation of the
patient’s medical history and a thorough clinical examination and
assessment of the patient’s general condition cannot be replaced
by any laboratory parameter. Novel markers such as PCT, IL-6, and
LBP seem not to give added value in the emergency room.
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Background Polymicrobial sepsis induced by cecal ligation and
puncture (CLP) causes a massive nitric oxide (NO) synthesis and
consequently several physiological alterations in cardiovascular
and hormonal systems. Central NO is reported to modulate the
secretion of vasopressin. Our aim was to study the central effect of
an unspecific NO synthase inhibitor (L-NAME) on the mean arterial
pressure (MAP), plasma nitrate levels (pNO), plasma arginine
vasopressin concentration (pAVP) and hypothalamic arginine vaso-
pressin mRNA content during polymicrobial sepsis induced by
CLP.
Methods  Male Wistar rats received an intracerebroventricular
injection of L-NAME (250 μg) or saline (vehicle) and 30 minutes later
they were submitted to CLP or to a sham operation. Animals were
decapitated 0, 4, 6, 20 or 24 hours after surgery and blood was
collected for pNO and pAVP measurements. The brains were
removed and the supraoptic and paraventricular nuclei were
punched out for vasopressin mRNA determination by real-time PCR.
In another set of animals the MAP was measured each 15 minutes
1 hour before and during 24 hours after surgery with intervals.
Results  CLP caused an increase in pNO after 6 hours, and in
pAVP at 4 and 6 hours, while the MAP decreased during 5 hours
after surgery. Hypothalamic vasopressin mRNA showed a tendency
to decrease in both nuclei. L-NAME pretreatment increased survival
(80% versus 67%), blocked pNO increase and MAP decrease and
also resulted in an increase in plasma vasopressin concentration in
the initial phase of sepsis (P <0.05). The vasopressin mRNA
content increased at 20 and 24 hours in the paraventricular
nucleus and only at 24 hours in the supraoptic nucleus.
Conclusion  These results demonstrate that central NO plays a
role in blood pressure and in vasopressin synthesis and release
during polymicrobial sepsis in rats.
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Background  Recent studies revealed that vasopressinergic
neurons have a high content of LTC4 synthase, a critical enzyme in
cys-leukotriene synthesis that may play a role in regulating
vasopressin secretion. The present study investigates the role of
this enzyme in arginine vasopressin (AVP) release during experi-
mentally induced sepsis.
Methods  Male Wistar rats received an intracerebroventricular
injection of MK 886 (1.0 μg/kg), a leukotriene (LT) synthesis
inhibitor, or vehicle, 1 hour before cecal ligation and puncture (CLP)
or sham operation. In one group of animals the survival rate was
monitored for 5 days. In another group, the animals were
decapitated 0, 4, 6, 18 and 24 hours after CLP or sham operation,
and blood was collected for hematocrit, serum sodium and nitrate,
plasma osmolality, protein and arginine AVP determination. The
neurohypophysis was removed for quantification of AVP content,
and the hypothalamus was dissected for LTC4 synthase analysis
by western blot.
Results The mortality rate after CLP was reduced by the central
administration of MK 886. The increase in plasma AVP levels and
hypothalamus LTC4 synthase content in the initial phase of sepsis
was blocked, whereas the decrease in neurohypophyseal AVP
content was partially reversed. The increase of serum nitric oxide
and hematocrit was reduced, and the decrease in plasma protein
and osmolality was not affected by the LT blocker. In the final
phase of sepsis, the plasma AVP level and the hypothalamic LTC4
synthase content were at basal levels. The central administration of
MK 886 increased the hypothalamic LTC4 synthase content but
did not alter the neurohypophysis AVP content and plasma AVP
levels observed during this phase.
Conclusion These results suggest that the central LTs are involved
in the vasopressin release observed during sepsis.
Acknowledgements  Financial support from FAPESP. Technical
support from Nadir Martins Fernandes.
P35
Systemic inflammatory response syndrome and severe sepsis
definitions outside the intensive care unit: contribution or
confusion?
Patrik Gille-Johnson, Karin Hansson, Bengt Gardlund
Department Infectious Diseases, Karolinska University Hospital,
Stockholm, Sweden
Critical Care 2008, 12(Suppl 5):P35 (doi: 10.1186/cc7068)
Background The terms systemic inflammatory response syndrome
(SIRS), sepsis, severe sepsis and septic shock were defined in
1992 and have been universally accepted. In the present study, the
prevalence of SIRS and severe sepsis in patients with significant
bacterial infections was assessed.
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Methods A total of 404 adult patients admitted to the Department
of Infectious Diseases from the emergency room (ER) for
suspected severe infection was studied prospectively. Laboratory
variables defining SIRS and severe sepsis were measured on
arrival while physiological variables were recorded on arrival in the
ER and every 4 hours for 24 hours.
Results  Bacterial infections requiring antibiotic treatment were
diagnosed in 306 patients. One hundred and fifty of these
developed severe sepsis during the first 24 hours. Significant
bacteremia was detected in 68 patients. In these three groups
26%, 22% and 21%, respectively, failed to meet two or more of
the SIRS criteria on arrival in the ER. In the group of patients that
did not have an infection nor did not need antibiotic treatment,
63% had SIRS on arrival. SIRS on arrival correlated significantly
with bacterial infection and development of severe sepsis, but not
with bacteremia. Of the SIRS criteria, only the respiratory rate and
white blood count contributed significantly to this finding; the heart
rate and temperature did not. Intensive care was required for
14/150 patients (9%) with severe sepsis and for 6/68 (9%)
bacteremic patients. Altogether 11/404 (2.7%) patients died
within 28 days.
Conclusion  As a tool for definition of sepsis and selection of
patients for clinical sepsis trials, SIRS lacks acceptable sensitivity
and specificity in a selected ER population with a high risk of
serious infection. Excluding patients with less than two or even
three SIRS criteria may exclude a large cohort of patients with
sepsis and result in biased enrollment to clinical trials. It may be
time to abandon the SIRS criteria as an entry criterion for sepsis
trials and to instead focus on more strict definitions of underlying
infections in association with sepsis-related hypoperfusion and
organ dysfunction. Many of the patients developed severe sepsis
within 24 hours, yet only a small proportion required intensive care,
putting the term severe sepsis into question. Severe sepsis in the
ICU setting is known to be associated with a high mortality,
whereas this might not be the case outside the ICU.
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Background Dendritic cells (DCs) play a key role in the initiation
and integration of innate and adaptive immune responses to
microbial infection. In contrast to neutrophils, macrophages or
lymphocytes, there are virtually no data on the time course of
circulating DCs in septic shock. Using a novel specific and
sensitive assay, we analyzed the evolution of circulating myeloid
DCs (mDCs) and plasmacytoid DCs (pDCs) in septic shock.
Methods  We enrolled immunocompetent adult patients with
septic shock (SS, n = 43) and with shock from other etiologies
(NSS, n = 29). Sixteen healthy controls (HC) were also used as
reference for mDCs and pDCs. Blood samples (200 μl) were
drawn on the day of shock, then after 3 and 7 days. DC analyses
were performed using the DC-labelling kit Trucount® assay (BD
Biosciences, San Jose, CA, USA). CD11c+CD123– cells (mDCs)
and CD11c–CD123+ cells (pDCs) were selected and counted by
flow cytometry (FACSCanto™; BD Biosciences). The HLA-DR
mean fluorescence index was measured.
Results The age, sex ratio, Simplified Acute Physiology Score II,
Sepsis-related Organ Failure Assessment score, nosocomial
infection (NI) and mortality rates did not statistically differ between
SS and NSS patients. On day 1, mDC and pDC counts were
significantly lower in both SS and NSS patients as compared with
controls (P <0.001). Patients with SS had significantly lower mDC
and pDC counts than NSS patients (P <0.001) both at day 1 and
day 3. The HLA-DR mean fluorescence index of mDCs and pDCs
was lower in SS patients compared with HC (P = 0.005 and
P = 0.037, respectively) but did not differ between other groups.
Interestingly, 10 out of the 43 SS patients developed NI after a
median time of 9 (7.5 to 11) days in the ICU. Whereas mDCs
increased in patients without NI, mDC counts remained low at day
7 in patients who developed NI: mDC counts and their relative
variation between day 1 and day 7 were significantly lower in
patients who developed NI than in those who did not (P <0.05).
Logistic regression analysis indicates that a negative mDC relative
variation is associated with an increased risk of nosocomial
infection with an odds ratio of 22 (2.53 to 191) (P = 0.005).
Conclusion  Circulating mDC and pDC counts are lower in SS
than in NSS as early as day 1. The persistence of a low count of
mDCs after SS seems to be associated with the advent of
nosocomial infection during the ICU stay.
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Background  Biomarkers may aid in risk triaging of systemic
inflammatory response syndrome (SIRS) patients at admittance to
hospital and in the monitoring of response to medical intervention.
The overall aim is reducing mortality in SIRS and sepsis patients.
Methods A prospectively collected cohort of patients with SIRS that
were admitted to an emergency department and a department of
infectious diseases at a Copenhagen University hospital were
studied. Samples obtained daily during hospitalization were
measured for soluble urokinase plasminogen activator receptor
(suPAR) using the CE/IVD-approved (the product complies with the
European Directives for In-Vitro Diagnostics) suPARnostic® assay
and were compared with various other clinical parameters asso-
ciated with assessing disease severity, including C-reactive protein,
procalcitonin, Simplified Acute Physiology Score II, and Sepsis-
related Organ Failure Assessment scores. Survival was assessed
using receiver operating curve statistics.
Results One hundred and fifty-one patients were included in the
study, nine of whom died within 30 days of admission. Admission
levels of suPAR were significantly higher in survivors compared
with nonsurvivors with an area under the curve of 0.80 and 0.92
when combined with age. Admission levels of procalcitonin and C-
reactive protein were not significantly different between survivors
and nonsurvivors. Simplified Acute Physiology Score II and Sepsis-
related Organ Failure Assessment scores were significant
predictors of death in this setting as well. During treatment,
survivors showed overall declining suPAR levels (Figure 1) while
continuously elevated suPAR levels were observed in nonsurvivors
(Figure 2).
Available online http://ccforum.com/supplements/12/S5S18
Conclusion The suPARnostic® assay provided significant informa-
tion on risk of mortality following admission. Continuous elevated
suPAR levels during treatment were associated with poor clinical
outcome.
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Background Methicillin-resistant Staphylococcus aureus (MRSA)
is now a common infection encountered in hospitals and
communities. We have previously shown that MRSA causes
reactive oxygen and nitrogen (ROS/RNS)-dependent increased
vascular permeability, multiorgan system failure and death in our
ovine model. Using type II alveolar epithelial cells (A549), we
hypothesized that MRSA increases expression of vascular endo-
thelial growth factor (VEGF), a regulator of vascular permeability to
water and proteins, and disrupts barrier function by disrupting
cytoskeletal integrity.
Methods  A549 cells were challenged with 105 colony-forming
units MRSA over a time course of 24 hours and were visualized for
markers of ROS/RNS formation (2,7-dichlorodihydrofluorescein),
as well as VEGF and actin expression by confocal imaging and
western blot analyses. Cellular permeability was measured by
quantifying FITC-dextran flow through a monolayer of A549 cells.
Results MRSA caused a significant 7.4-fold increase in 2,7-dichloro-
dihydrofluorescein fluorescence over unchallenged controls. L-NAME,
an inhibitor of nitric oxide formation, blocked this response.
Western blot analyses confirmed the confocal observations that
MRSA caused an 8.15-fold increase in VEGF expression, versus
cells that were pre-incubated with L-NAME (3.4-fold). MRSA also
induced formation of actin stress fibers and subsequent cellular
contraction. In support of these observations, MRSA caused a
405% increase in cellular permeability to FITC-dextran. However,
pre-incubation with L-NAME had no effect on MRSA-induced
barrier dysfunction.
Conclusion  MRSA induces VEGF expression in a ROS/RNS-
dependent manner. MRSA also causes alveolar epithelial cell
barrier dysfunction by disrupting the actin cytoskeleton
independent of nitric oxide synthase activity. Together, the data
suggest that MRSA-increased vascular permeability in the lung
may be due, in part, to disruption of the cytoskeletal integrity and
increased expression of VEGF, but the overall mechanism involves
multiple pathways and requires further study.
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Background  Sepsis is characterized by systemic inflammation
(systemic inflammatory response syndrome (SIRS)), leading to
multiple organ failure and death. The lung and liver are both prone
to septic-induced damage resulting from leukocyte infiltration,
cellular apoptosis, and epithelial/endothelial breakdown. Furthermore,
coagulation can potentiate the inflammatory response and
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Figure 1 (abstract P37)
suPAR levels among surviving SIRS patients during treatment. Dotted
line, mean suPAR among patients with an inclusion suPAR >5 ng/ml
(n = 50). Dashed line, suPAR levels among patients with an inclusion
suPAR <5 ng/ml (n = 68).
Figure 2 (abstract P37)
suPAR levels among patients who either had severe complications
(n = 14) or died (n = 9) within 30 days of hospitalization. Dotted line,
mean suPAR for the 23 patients.S19
contribute to septic mortality. Phosphoinositide-3 kinase gamma
(PI3Kγ) plays a dominant role in the inflammatory response;
however, its role in the pathogenesis of sepsis, specifically SIRS,
lung/liver inflammation and damage, apoptosis, coagulation and
mortality remains unknown. We hypothesized that mice lacking
PI3Kγ or possessing a kinase-dead enzyme will be protected
against septic-induced injury.
Methods PI3Kγ wild-type (WT), knockout (KO) and kinase dead
(KD) mice were randomized to cecal ligation and perforation
(CLP)-induced sepsis or a sham laporatomy. After 18 hours,
plasma and bronchoalveolar lavage and/or lung and liver tissue
were collected. Plasma was assessed for inflammatory mediators
and the lung/liver was analysed for pathology score, leukocyte
infiltration, inflammatory mediators, edema, apoptosis, coagulation
and downstream intracellular signalling of PI3Kγ. A separate cohort
of WT and KO mice were used for evaluation of 7-day survival
following CLP.
Results Systemically, KO and KD mice showed a reduction in five
of 22 measured cytokines/chemokines (MIP1a, MIP2, RANTES,
MCP1 and IL-10) compared with WT controls. In the lungs, KO
and KD mice were significantly protected against septic damage,
as observed by decreased pathology scores, edema/permeability,
leukocyte infiltration, inflammation (all 22 measured mediators),
apoptosis and Akt/mitogen-activated protein kinase activation, com-
pared with WT lungs. Similarly, livers of CLP-exposed KO and KD
mice had decreased pathology scores, leukocyte infiltration, apop-
tosis and coagulation derangements compared with WT controls.
Furthermore, Kaplan–Meier analysis of 7-day survival following
CLP showed KO mice had significantly reduced mortality
compared with WT mice. See Table 1.
Conclusion The present study demonstrates that while PI3Kγ has
a modest effect on SIRS during sepsis, its kinase activity is pivotal
to the successive development of coagulation derangement and
lung/liver inflammation and damage, probably through the
modification of leukocyte recruitment and apoptosis. Furthermore,
PI3Kγ is shown to effect CLP-septic-induced mortality, implying
that it may be a possible therapeutic target in sepsis and multiple
organ failure.
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Background Recently, a reciprocal relationship has been known
between anti-inflammation and anticoagulation responses to
infection. In our previous studies, protein C (PC) deficiency and
antithrombin III (AT III) deficiency have been shown in septic
patients. Moreover, these AT III deficiencies in sepsis did not relate
to their disseminated intravascular coagulation (DIC) status. We
hypothesize that PC activity relates to AT III activity in septic
patients without DIC status.
Materials  Fifty ICU patients were included in this study and
divided into three groups by primary diagnosis on admission;
trauma patients, nonseptic patients, and septic patients. The
patients who had already DIC on admission were excluded.
Methods  Serum PC activity (%) (Diagnostica Stago®, Tokyo,
Japan) and serum AT III activity (%) (Sysmex®, Kobe, Japan) were
measured on admission. PC and AT III activities were compared
between three groups. Values are expressed as the median. Data
were analyzed by the Kruskal–Wallis test and the Mann–Whitney
U test. Pearson’s correlation coefficient was used for correlation.
P <0.05 was considered statistically significant.
Results There were 23 trauma patients, 12 nonseptic patients and
15 septic patients. PC activity was significantly lower in septic
patients than in trauma or in nonseptic patients (54.6 versus 85.6,
Available online http://ccforum.com/supplements/12/S5
Table 1 (abstract P39)
Portion of results displaying the systemic, lung, liver and coagulation responses of PI3Kγ γ WT, KO and KD mice to CLP-induced sepsis
WT sham KO sham KD sham WT CLP KO CLP KD CLP
Systemic response
MIP-2 concentration (pg/ml in plasma x 104) 0 ± 0 0 ± 0 0 ± 0 13 ± 5** 2 ± 1* 2 ± 1*
IL-6 concentration (pg/ml in plasma x 103) 0 ± 0 0 ± 0 0 ± 0 18 ± 5* 19 ± 10* 22 ± 8*
Lung injury
Pathology score 1.67 ± 0.42 1.8 ± 0.49 1.71 ± 0.42 4.17 ± 0.31* 2.00 ± 0.63 2.00 ± 0.45
Permeability (protein in BAL (μg/ml)) 194 ± 7 199 ± 3 195 ± 8 234 ± 13* 191 ± 13 192 ± 10
Neutrophil infiltration (cell x 103/ml BAL) 0.3 ± 0.2 0.8 ± 0.4 0.2 ± 0.2 11.7 ± 5.9* 0.2 ± 0.1 0.8 ± 0.3
MIP-2 concentration (pg/ml in BAL x 102) 0 ± 0 0 ± 0 0 ± 0 21.6 ± 1.0* 1.1 ± 0.4 1.2 ± 0.5
IL-6 concentration (pg/ml in BAL x 102) 0 ± 0 0 ± 0 0 ± 0 14 ± 5* 1 ± 0 2 ± 0
Apoptosis (% apoptotic cells) 0.3 ± 0.1 1.2 ± 0.2* 1.0 ± 0.2* 7.7 ± 0.8** 1.3 ± 0.3* 1.2 ± 0.3*
Akt phosphorylation (fold increase over WT sham) 1.0 ± 0.1 0.7 ± 0.0* 0.7 ± 0.1* 1.4 ± 0.1** 0.8 ± 0.1* 0.8 ± 0.1*
Liver injury
Pathology score 0.33 ± 0.21 0.20 ± 0.20 0.20 ± 0.20 2.83 ± 0.17** 1.20 ± 0.37* 1.83 ± 0.17*
Apoptosis (% apoptotic cells) 1.0 ± 0.2 4.6 ± 1.2* 4.3 ± 1.0* 23.9 ± 2.7** 5.6 ± 0.7* 4.9 ± 1.0*
Coagulation
tPA (pg/ng protein) 404 ± 17 369 ± 53 423 ± 23 1 ± 1** 104 ± 36* 61 ± 31*
PAI-1 (pg/μg protein) 2.9 ± 0.2 2.7 ± 0.2 3.1 ± 0.4 84.8 ± 13.4** 50.5 ± 9.2* 52.0 ± 9.0*
Fibrinogen (ng/mg protein) 805 ± 35 807 ± 40 779 ± 33 1424 ± 89** 1043 ± 57* 1079 ± 58*
BAL, bronchoalveolar lavage; tPA, tissue plasminogen activator; PAI-1, plasminogen activator inhibitor 1.S20
94.0% respectively, P = 0.0006). AT III activity was also lower in
septic patients than in other groups (54.2 versus 94.4, 81.2%
respectively, P <0.001). There were correlations of PC activity with
AT III activity in trauma patients (r = 0.76, P <0.0001) and in non-
septic patients (r = 0.61, P = 0.048). Especially, in septic patients,
PC activity had significant correlation with AT III activity (r = 0.91,
P <0.0001).
Conclusion Both PC deficiency and AT III deficiency had already
been shown in septic patients on admission to the ICU, but
nevertheless no DIC status. The relationship between PC activity
and AT III activity was found in all patients and there could be a
definite correlation in septic patients.
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Background  Granulocytes or polymorphonuclear cells (PMN)
represent the majority of leukocytes in peripheral blood. As
terminally differentiated cells, they contain few ribosomes and
assist innate immunity mainly through phagocytosis and
degranulation. Whether or not they can release proinflammatory
cytokines such as TNFα and IL-1β has been a controversial issue.
To clarify the role of PMN in this aspect, lipopolysaccharide (LPS)-
induced cytokine secretion from PMN was analyzed at the single-
cell level with the ELISpot technique.
Methods PMN and peripheral blood mononuclear cells (PBMC)
from healthy human donors were prepared by gradient-based
centrifugation to a purity >98%. ELISpot assays were used for
detection of a large panel of inflammatory mediators. Cells were
stimulated with endotoxin (LPS, 100 ng/ml) for 20 hours and the
numbers of secreting cells were quantified with an ELISpot reader.
For comparison, cytokine production was also analyzed by ELISA.
In some experiments, PBMC were depleted of monocytes using
anti-CD14 magnetic beads.
Results  Purified PMN secreted IL-8 and MIP-1β and a sub-
population also released TNFα after LPS stimulation. In contrast
and different from some earlier reports, we were unable to detect
secretion of IL-1β, IL-12, granulocyte–macrophage colony-stimu-
lating factor, IL-6 or IFNγ. Furthermore, granulocytes did not
secrete the cytotoxic molecules perforin or granzyme B in
response to LPS. Compared with the limited cytokine production
by PMN, PBMC secreted significant amounts of all substances
investigated and were found to require a 100x lower concentration
of LPS than granulocytes to obtain the maximum number of
responding cells. In addition, CD14+ monocytes were found to be
the primary source of production.
Discussion By use of the ELISpot method we could establish the
cytokine profiles for both PBMC and PMN based on the frequency
and pattern of cytokine secreting cells, rather than the amount of
produced cytokine as by ELISA. This way, low levels of
contaminating monocytes present in our PMN preparations could
be discriminated from the granulocytes. Additionally, we could
demonstrate that ELISpot, compared with ELISA, not only provides
a more sensitive means of detection but potentially gives
biologically more relevant information.
Conclusion  LPS-stimulated PMN were shown to secrete IL-8,
MIP-1β and TNFα but not IL-1β, IL-6, IL-10, IL-12, granulocyte–
macrophage colony-stimulating factor, IFNγ, perforin or granzyme
B. Our findings suggest that the ELISpot assay may be a suitable
tool in further studies of cellular signaling.
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Background  Severe sepsis is a highly fatal condition, but the
prognostic factors of severe sepsis are not yet fully understood.
Materials  One thousand and twenty-six severe sepsis patients
(community-acquired infection only) were registered in the Korean
Sepsis Registry System from May 2005 to November 2007. The
Korean Sepsis Registry System is a web-based ongoing prospective
data collection system from 12 tertiary referral hospitals in Korea.
Methods The Acute Physiology and Chronic Health Evaluation II
score, Serial Organ Failure Assessment (SOFA) at admission and
serial 1 to 4 days after admission, demographic characteristics,
comorbidity conditions with the Charlson score, Glasgow coma
scale, organ dysfunction index, infection site, organism, and
laboratory data at admission of 1,026 severe sepsis patients were
analysed and evaluated to determine the association with 7-day
mortality respectively. To develop a prognostic model, decision
tree analysis was carried out with SAS 9.1.
Results The 7-day mortality rate was 13.6/100 patients. Age was
an independent risk factor, but the highest mortality (25.3%) was
seen in the 60 to 69 years age group. The greater the number of
organ dysfunctions, the higher the mortality. The underlying
conditions were not statistically significant as a risk factor of 7-day
mortality except liver diseases (P = 0.0015). The blood pressure,
Charlson score, Acute Physiology and Chronic Health Evaluation II
score and SOFA score at admission were all significantly
associated with mortality. The initial laboratory values of
hemoglobin, white blood cells, platelets, fibrinogen, prothrombin
time, partial prothrombin time, arterial pH, potassium and albumin
at admission were also statistically significant in bivariate analysis.
Systemic infection and central nervous system infection showed
26.7% and 25.0% 7-day mortality. In a prognostic model by
decision tree analysis, the blood coagulation factors (prothrombin
time, platelet) and SOFA at 5 days after admission were the most
significant prognostic factors of 7-day mortality. The sensitivity and
specificity of this model were 67.5% and 96.8%, respectively.
Conclusion The blood coagulation factors and SOFA were the
most significant prognostic factors of 7-day mortality.
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Background Blood culture is an important method for identifying
the underlying microorganism causative of sepsis. However,
appropriate antibiotic therapy may possibly be delayed due to the
long time to results for culture-based methods. Nucleic acid
amplification (NAT) of microbial DNA may significantly shorten the
time to pathogen detection but clinical data for this technique are
missing. The goal of the present study was to compare a new NAT
protocol with blood culture results in critically ill patients with
evidence of infection.
Methods  Patients either with severe sepsis (sepsis group) or
systemic inflammatory response syndrome without evidence of
infection (control group) were included. A blood culture (BC) was
obtained and 10 ml ethylenediamine tetraacetic acid blood was
simultaneously taken by sterile venous puncture. Microbial DNA
was measured using NAT-based pathogen detection with multiplex
PCR testing for 45 targets (VYOO®; SIRS-Lab, Jena, Germany).
Results Thirty-six samples from 24 septic patients (age 66.0 ± 3.4
years) and 32 samples from 22 control patients (age 64.6 ± 5.1
years) were obtained. The PCRs of all control patients were
negative while five BCs from the control group (15.6%, P = 0.06)
were positive. In sepsis patients, five BCs (13.4%) tested positive
compared with 14 positive PCRs (38.9%, P = 0.03). Median
procalcitonin levels were higher in PCR-positive tested sepsis
patients (7.0 ng/ml; interquartile range, 1.5 to 14.5) compared with
patients with negative PCR (1.8 ng/ml; interquartile range, 1.0 to
6.2). However, the difference did not reach statistical significance
(P = 0.15). No similar correlation between procalcitonin and
findings of BC were observed. Procalcitonin for negative BCs was
2.4 ng/ml (1.4 to 7.6), and was 2.1 ng/ml (0.4 to 9.2, P = 0.35) for
positive BCs.
Conclusion Multiplex PCR detected pathogens significantly more
often than the concomitant BC, while there was no rate of false
positive results in patients without evidence of infection. Positive
PCRs were associated with higher serum procalcitonin levels, thus
suggesting the clinical importance of a positive PCR result. Larger
sample sizes are needed to confirm these observations.
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Background  Cell membrane-bound receptor for advanced
glycation end products (RAGE) is a major receptor for HMGB1.
RAGE also circulates in soluble form – sRAGE, which binds
circulating HMGB1 and inhibits its proinflammatory actions.
Materials  HMGB1, sRAGE, IL-6, IL-10 and TNFα levels were
studied over 5 hours in 16 healthy volunteers exposed to endo-
toxin, and HMGB1 and sRAGE over 4 days in 45 patients with a
diagnosis of severe sepsis or septic shock.
Methods HMGB1 and sRAGE were measured using ELISA.
Results  Eleven out of 16 volunteers had measurable levels of
HMGB1 at baseline, before endotoxin injection. Within 2 hours of
endotoxin injection, parallel to the rise of IL-6, IL-10 and TNFα,
HMGB1 increased more than fourfold in 12/16 volunteers (from
baseline 0.52 (0 to 1.05) to 2.3 (1.63 to 4.42) (median, inter-
quartile range)). In four volunteers, levels diminished after
endotoxin was injected. sRAGE increased in all volunteers during
the studied period. In 11 out of 16 volunteers, HMGB1 and
sRAGE were released in patterns that seemed to be inversely
related, suggesting mutual negative regulation. We went on to
study release patterns of HMGB1 and sRAGE at days 0, 1 and 4
in patients with severe sepsis or septic shock. In 36/45 patients,
the increase or decrease of HMGB1, between at least two time
points, was opposite to the change in sRAGE levels, again
suggesting mechanisms of negative regulation between the two.
Conclusion (1) sRAGE and circulating HMGB1 have release
patterns that suggest mutual negative regulation. Further studies
are needed to evaluate sRAGE as a therapeutic means for
reducing harmful HMGB1 levels in various inflammatory conditions.
(2) HMGB1 is not only a late mediator of inflammation. It increased
fourfold within 2 hours of endotoxin injection in healthy volunteers,
parallel to the rise of IL-6, IL-10 and TNFα. (3) HMGB1 circulates
at measurable levels in healthy individuals.
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Background  Upregulation and downregulation of inflammatory
response was described in blood cells from septic patients,
according to the stage of sepsis and the cells evaluated. This study
aimed to evaluate the Toll-like receptor (TLR) signaling pathway
gene expression in peripheral blood mononuclear cells (PBMC) and
neutrophils in patients throughout the different stages of sepsis.
Methods Septic patients admitted to two emergency rooms and
two ICUs in one university and one teaching hospital were enrolled
in the study, including five with sepsis, five with severe sepsis and
five with septic shock. Five healthy volunteers were enrolled as
controls. The Human-TLR Signaling Pathway, which comprises 84
genes related to TLR-mediated signal transduction, was evaluated
by real-time PCR in PBMC and neutrophils obtained from patients
and controls. Results were expressed as CT and were normalized
with the housekeeping gene 18SrRNA (ΔCT). The fold change for
each gene (2–ΔΔCT) was compared between the groups. Genes
with fold changes greater than two and significant changes in ΔCT
are reported as differently expressed.
Results The fold change ratios in PBMC gene expression between
septic patients and healthy controls revealed a dynamic process
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according to the stage of sepsis, tending towards downregulation
of the TLR signaling pathway in PBMC in the more severe forms of
the disease. In patients with sepsis and severe sepsis, fold-change
analyses showed upregulated genes mostly in TLR receptors and
adaptor or TLR interacting protein groups. The downregulated
genes consisted mostly of downstream pathways and target
genes, and they included the NFκB, JNK/p38 pathway, and
effectors. However, the differential gene expression was restricted
to five downregulated genes in septic shock patients, which are
found in the effector and downstream pathways. Neutrophils
showed a different pattern of adaptation. Patients with sepsis,
severe sepsis and septic shock presented a broad gene
upregulation, which included all functional groups evaluated and
persisted throughout the stages of the disease.
Conclusion TLR-signaling pathway genes are differently regulated
in PBMC and neutrophils of septic patients, and are dynamically
modulated throughout the different stages of sepsis.
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Background Tolerance to lipopolysaccharide (LPS) occurs when
animals or cells exposed to LPS become hyporesponsive to a
subsequent challenge of LPS. This mechanism is believed to be
involved in the downregulation of cellular responses observed in
patients with severe sepsis and septic shock. The aim of the
present investigation was to evaluate the induction of tolerance in
monocytes of healthy volunteers, in whole blood, after LPS
exposition in vitro, assessed by intracellular cytokine detection and
reactive oxygen species (ROS) generation.
Methods Peripheral blood cells were conditioned with small doses
of LPS for 18 hours and challenged with different agonists of Toll-
like receptors (macrophage-activating lipopeptide-2, flagellin and
LPS) and whole Gram-negative (Pseudomonas aeruginosa) and
Gram-positive (Staphylococcus aureus) killed bacteria. For
detection of intracellular IL-6, samples of whole blood were
stimulated for 6 hours. Monocytes were identified by forward-
scatter and side-scatter parameters and CD14-positive staining.
The samples were stained to verify the intracellular production of
IL-6 on monocytes by flow cytometry. For induction of ROS, whole
blood was stimulated for 30 minutes with LPS, P. aeruginosa and
S. aureus. ROS production was measured by flow cytometry,
using 2′,7′-dichlorfluorescein-diacetate detection.
Results The conditioning with increasing doses of LPS resulted in
lower intracellular detection of IL-6 in monocytes after the
challenge with LPS. A similar effect was observed with
macrophage-activating lipopeptide-2, P. aeruginosa, and
S. aureus, but not with flagellin. LPS conditioning with 15 ng/ml
LPS, on the other hand, resulted in preserved or increased
production of ROS in monocytes after challenge with LPS,
P. aeruginosa and S. aureus.
Conclusion  The phenomenon of tolerance involves a complex
regulation, in which the production of proinflammatory cytokines,
such as IL-6, is diminished, whereas the production of ROS is
preserved or even increased.
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Background A positive blood culture (BC) is considered the gold-
standard method for sepsis diagnosis, although its sensibility is low
(10% to 30%) – which demands a better diagnostic tool to limit
broad-spectrum antibiotic use in the majority of patients without
culture-based sepsis diagnosis. Besides, after microbial invasion,
bacteria can remain dead or fragmented in the circulation, thus
limiting BC efficiency. Herein we evaluated the PCR diagnostic
efficacy under live, dead and fragmented bacteria contents in the
bloodstream.
Methods Wistar rats were distributed into three groups (n = 20/
group) based on live, dead and DNA inoculations. Another
lipopolysaccharide (LPS) + DNA group (1 mg/kg LPS injection
plus 4 hours later DNA injection, n = 10) was designed for DNA
detection under an induced inflammatory state. Live, dead and
extracted DNA forms of Pseudomonas aeruginosa (ATCC 27853),
107 colony-forming units/ml/100 g body weight, were injected into
the tail vein of respective groups. Blood samples were collected
after 20 minutes (n = 10) and 6 hours (n = 10) from all groups
except for the LPS + DNA group (6 hours), and were submitted to
a nested PCR assay using general and specific primers. BC was
performed only in the live group.
Results In the live group at 20 minutes the sensibility was 100%
by both BC and PCR, and at 6 hours the sensitivity was 60% to
BC and 80% to PCR. In the dead group, the PCR sensitivity was
90% at 20 minutes and 50% at 6 hours. In the DNA group, the
sensitivity was 90% at 20 minutes and 40% at 6 hours, and in the
LPS + DNA group at 6 hours the sensitivity was 40%.
Conclusion The sensitivity of the PCR was as effective as BC in
20 minutes and superior in 6 hours. Besides, the PCR assay was
able to detect circulating dead bacteria and bacterial DNA in the
blood, which is not possible by the BC method. These findings
suggest that the live bacteria remains for a short period of time in
the bloodstream as compared with dead and DNA bacteria, and a
systemic inflammation state seems to not interfere with the PCR
assay. Besides, the PCR tool with specific primers can be a useful
method for sepsis diagnosis in the negative blood culture
conditions as well as in specific bacterial surge events in the ICU,
thus improving the antibiotic usage potentials.
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Background  Clinical signs of sepsis often overlap with other
symptoms present in patients after trauma, surgery and chemo-
therapy, amongst others. The clinical utility of existing biomarkers
to detect sepsis, such as procalcitonin (PCT) and C-reactive
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protein (CRP), is limited in patients suffering from shock and organ
dysfunction. As a result, tests with superior positive and negative
predictive values are mandatory in life-threatening infection.
Methods We have analyzed the clinical utility of a new class of
transcriptomic biomarkers derived from circulating leukocytes.
Prospectively collected whole blood samples from 460 patients
admitted to the operative ICU of the University Hospital Jena were
used in a microarray/quantitative PCR study to identify sensitive
and specific biomarkers. Microarrays comprising 5,308 probes
corresponding to 3,704 human genes relevant to inflammation,
immune response and related processes were used for analysis.
The identification of a signature specific for the discrimination
between systemic inflammatory response syndrome and sepsis in
patients suffering from shock and organ dysfunction was
performed in independent training and test phases. The training set
of 96 patients was selected by an independent ICU committee. An
algorithm was established combining and transforming the gene-
expression signals into a continuous, nondimensional score
indicating either infectious or noninfectious causes for organ
dysfunction. The resulting classificator was validated in a test set
comprising 1,784 ICU days of 364 patients. For each marker, a
robust quantitative PCR assay was established.
Results The final microarray signature could be transferred into a
multiplex quantitative PCR format retaining full sensitivity and
specificity with a time to result of approximately 5 hours. Moreover,
it could be demonstrated that the combination of seven biomarkers
possesses the same accuracy compared with the complete
biomarker set. The area under the curve in the test group was
determined as 0.79 (PCT – 0.65, CRP – 0.67). Moreover, the
quantitative PCR assay determined the onset of sepsis up to
48 hours prior to the clinical diagnosis backed by daily CRP and
PCT testing.
Conclusion  With its high predictive value for the differentiation
between infectious and noninfectious causes of shock and organ
dysfunction, this new class of biomarkers may help to identify
patients with life-threatening infections among patients at risk and
to guide therapy (for example, with anti-infective agents).
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Background Central venous catheters (CVCs) are very useful in
the management of patients hospitalized in the ICU. Among the
complications related to the permanence of CVCs, infection
stands out. This may increase the morbidity and mortality, cost and
length of stay in the ICU. A comparative study between antiseptic-
impregnated and standard catheters is therefore of great value.
Objective To compare the duration of standard CVCs with those
that are antiseptic-impregnated: silver sulfadiazine and chlorhexidine.
Methods  A prospective study was performed, in a randomized,
alternate, and nonblind fashion. The measure of Acute Physiology
and Chronic Health Evaluation II score and central venous access
were made alternating the type of CVC used in each patient, so
the study was randomized. The information recorded on each
patient was sex, Glasgow coma score, site of the puncture, reason
for withdrawal of the catheter and the type of catheter used. We
cultured (qualitatively) the tip of the catheter. The patients were
divided into two groups: group I (36 patients, 47 punctures) used
the standard CVC, and group II (33 patients, 47 punctures) used
the impregnated CVC.
Results Length of duration: group II = 14.2 days, group I = 10.2
days. Excluding death in both groups, length of stay: group I =
10.4 days, group II = 15.8 days. Adding all periods of
catheterization for each group: group I = 483 days, group II = 670
days. The total duration of group II was 38.71% higher than that of
group I. Regarding the reason for withdrawal of the CVC,
predominant was suspected infection in 74.6% of standard CVCs
and in 48.9% of impregnated CVCs. The culture of the catheter tip
was positive on 10 occasions (21.2%) in standard CVCs, against
six occasions (12.7%) in impregnated CVCs. Most patients had
Glasgow coma score <9. Average Acute Physiology and Chronic
Health Evaluation II score: 17.8 in group I, 20.2 in group II. The
predominant site of puncture was the subclavian vein (56.3%), and
the catheters remained much of the time on this site when
compared with the other sites used (jugular and femoral). But
when we take only group II into consideration, the catheters
located in the jugular vein remained longer.
Conclusion The length of stay with the use of impregnated CVCs
was higher (15.8 days) than that for the standard CVCs
(10.4 days). The rate of infection was higher in the standard CVCs.
Patients who require CVCs for long periods have benefited with
the use of impregnated CVCs, because they present long-term
use, lower rates of infection, and avoidance of successive
punctures and risks of the procedure. In view of the clinical
benefits already mentioned, the benefit reached by the use of
antiseptic-impregnated catheters compensated the initial extra
expensive cost of 40%.
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